{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:08:11Z","timestamp":1792145291986,"version":"4.4.0"},"reference-count":395,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are two interrelated inflammatory diseases affecting patients above 50 years of age. Patients with GCA suffer from granulomatous inflammation of medium- to large-sized arteries. This inflammation can lead to severe ischemic complications (e.g., irreversible vision loss and stroke) and aneurysm-related complications (such as aortic dissection). On the other hand, patients suffering from PMR present with proximal stiffness and pain due to inflammation of the shoulder and pelvic girdles. PMR is observed in 40\u201360% of patients with GCA, while up to 21% of patients suffering from PMR are also affected by GCA. Due to the risk of ischemic complications, GCA has to be promptly treated upon clinical suspicion. The treatment of both GCA and PMR still heavily relies on glucocorticoids (GCs), although novel targeted therapies are emerging. Imaging has a central position in the diagnosis of GCA and PMR. While [<jats:sup>18<\/jats:sup>F]fluorodeoxyglucose (FDG)-positron emission tomography (PET) has proven to be a valuable tool for diagnosis of GCA and PMR, it possesses major drawbacks such as unspecific uptake in cells with high glucose metabolism, high background activity in several non-target organs and a decrease of diagnostic accuracy already after a short course of GC treatment. In recent years, our understanding of the immunopathogenesis of GCA and, to some extent, PMR has advanced. In this review, we summarize the current knowledge on the cellular heterogeneity in the immunopathology of GCA\/PMR and discuss how recent advances in specific tissue infiltrating leukocyte and stromal cell profiles may be exploited as a source of novel targets for imaging. Finally, we discuss prospective novel PET radiotracers that may be useful for the diagnosis and treatment monitoring in GCA and PMR.<\/jats:p>","DOI":"10.3389\/fmed.2022.902155","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T05:44:54Z","timestamp":1654494294000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":31,"title":["Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica"],"prefix":"10.3389","volume":"9","author":[{"given":"Kornelis S. M.","family":"van der Geest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sandovici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter H.","family":"Nienhuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riemer H. J. A.","family":"Slart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Heeringa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F.","family":"Jiemy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-021-02450-w","article-title":"A meta-analysis of the epidemiology of giant cell arteritis across time and space","volume":"23","author":"Li","year":"2021","journal-title":"Arthritis Res Ther."},{"key":"B2","doi-asserted-by":"publisher","first-page":"623716","DOI":"10.3389\/fimmu.2021.623716","article-title":"The immunopathology of giant cell arteritis across disease spectra","volume":"12","author":"Robinette","year":"2021","journal-title":"Front Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/nrrheum.2017.142","article-title":"Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities","volume":"13","author":"Dejaco","year":"2017","journal-title":"Nat Rev Rheumatol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1001\/jamainternmed.2020.3050","article-title":"Diagnostic accuracy of symptoms, physical signs, and laboratory tests for giant cell arteritis: a systematic review and meta-analysis","volume":"180","author":"Van Der Geest","year":"2020","journal-title":"JAMA Intern Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"4958","DOI":"10.3390\/jcm10214958","article-title":"Functionally heterogenous macrophage subsets in the pathogenesis of giant cell arteritis: novel targets for disease monitoring and treatment","volume":"10","author":"Esen","year":"2021","journal-title":"J Clin Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"102995","DOI":"10.1016\/j.autrev.2021.102995","article-title":"Immune system activation in polymyalgia rheumatica: which balance between autoinflammation and autoimmunity? A systematic review","volume":"21","author":"Hysa","year":"2022","journal-title":"Autoimmun Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.semarthrit.2020.07.005","article-title":"Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: a systematic literature review","volume":"50","author":"Sharma","year":"2020","journal-title":"Semin Arthritis Rheum."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e001652","DOI":"10.1136\/rmdopen-2021-001652","article-title":"Need and value of targeted immunosuppressive therapy in giant cell arteritis","volume":"8","author":"Sandovici","year":"2022","journal-title":"RMD Open."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003432","article-title":"Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: a population-based cohort study","author":"Pujades-Rodriguez","year":"2020","journal-title":"PLoS Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1056\/NEJMoa1613849","article-title":"Trial of tocilizumab in giant-cell arteritis","volume":"377","author":"Stone","year":"2017","journal-title":"N Engl J Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1136\/annrheumdis-2015-208742","article-title":"Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study","volume":"75","author":"Devauchelle-Pensec","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1136\/annrheumdis-2021-221126","article-title":"Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE): a phase 2\/3 randomised controlled trial","volume":"81","author":"Bonelli","year":"2022","journal-title":"Ann Rheum Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"2010","journal-title":"Arthritis Rheum."},{"key":"B14","doi-asserted-by":"publisher","first-page":"549","DOI":"10.3949\/ccjm.87a.20008","article-title":"Bin, Nelson E, Padniewski J, Nasr R. Polymyalgia rheumatica: an updated review","volume":"87","author":"Mahmood","year":"2020","journal-title":"Cleve Clin J Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1093\/rheumatology\/key383","article-title":"Vessel wall plasticity in large vessel giant cell arteritis: an ultrasound follow-up study","volume":"58","author":"Aschwanden","year":"2019","journal-title":"Rheumatology."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3886","DOI":"10.1007\/s00259-021-05362-8","article-title":"Diagnostic value of [18F]FDG-PET\/CT for treatment monitoring in large vessel vasculitis: a systematic review and meta-analysis","volume":"48","author":"van der Geest","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1007\/s00259-020-05162-6","article-title":"Diagnostic value of [18F]FDG-PET\/CT in polymyalgia rheumatica: a systematic review and meta-analysis","volume":"48","author":"van der Geest","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"2018 Update of the EULAR recommendations for the management of large vessel vasculitis","volume":"79","author":"Hellmich","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.semarthrit.2020.04.002","article-title":"Visual and semiquantitative assessment of cranial artery inflammation with FDG-PET\/CT in giant cell arteritis","volume":"50","author":"Nienhuis","year":"2020","journal-title":"Semin Arthritis Rheum."},{"key":"B20","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1007\/s00259-018-4106-0","article-title":"Simple dichotomous assessment of cranial artery inflammation by conventional 18F-FDG PET\/CT shows high accuracy for the diagnosis of giant cell arteritis: a case-control study","volume":"46","author":"Nielsen","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B21","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1053\/j.semnuclmed.2021.06.008","article-title":"Limitations and pitfalls of FDG-PET\/CT in infection and inflammation","volume":"51","author":"Pijl","year":"2021","journal-title":"Semin Nucl Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s00259-018-4021-4","article-title":"Three days of high-dose glucocorticoid treatment attenuates large-vessel 18F-FDG uptake in large-vessel giant cell arteritis but with a limited impact on diagnostic accuracy","volume":"45","author":"Nielsen","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B23","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/cmi.2017.5","article-title":"Glucocorticoid receptor promotes the function of myeloid-derived suppressor cells by suppressing HIF1\u03b1-dependent glycolysis","volume":"15","author":"Lu","year":"2018","journal-title":"Cell Mol Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1038\/bcj.2011.27","article-title":"Glucocorticoid-induced cell death is mediated through reduced glucose metabolism in lymphoid leukemia cells","volume":"1","author":"Buentke","year":"2011","journal-title":"Blood Cancer J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1016\/S0002-9440(10)64458-6","article-title":"Trapping of misdirected dendritic cells in the granulomatous lesions of giant cell arteritis","volume":"161","author":"Krupa","year":"2002","journal-title":"Am J Pathol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/art.1780400105","article-title":"Disease patterns and tissue cytokine profiles in giant cell arteritis","volume":"40","author":"Weyand","year":"1997","journal-title":"Arthritis Rheum."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1136\/annrheumdis-2018-213488","article-title":"Interleukin 12 and interleukin 23 play key pathogenic roles in inflammatory and proliferative pathways in giant cell arteritis","volume":"77","author":"Conway","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1136\/annrheumdis-2012-201836","article-title":"Increased IL-17A expression in temporal artery lesions is a predictor of sustained response to glucocorticoid treatment in patients with giant-cell arteritis","volume":"72","author":"Esp\u00edgol-Frigol\u00e9","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1093\/rheumatology\/kev102","article-title":"Difference in the expression of IL-9 and IL-17 correlates with different histological pattern of vascular wall injury in giant cell arteritis","volume":"54","author":"Ciccia","year":"2015","journal-title":"Rheumatology."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.3389\/fimmu.2019.01638","article-title":"Decreased expression of negative immune checkpoint VistA by CD4+ T cells facilitates T helper 1, T helper 17, and T follicular helper lineage differentiation in GCA","volume":"10","author":"Cadena","year":"2019","journal-title":"Front Immunol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"E970","DOI":"10.1073\/pnas.1616848114","article-title":"Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis","volume":"114","author":"Zhang","year":"2017","journal-title":"Proc Natl Acad Sci USA."},{"key":"B32","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/1529-0131(200001)43:1<184::AID-ANR23>3.0.CO;2-N","article-title":"Cell adhesion molecules in the development of inflammatory infiltrates in giant cell arteritis: inflammation-induced angiogenesis as the preferential site of leukocyte-endothelial cell interactions","volume":"43","author":"Cid","year":"2000","journal-title":"Arthritis Rheum."},{"key":"B33","doi-asserted-by":"publisher","first-page":"6553","DOI":"10.1038\/s41598-017-06826-4","article-title":"Involvement of monocyte subsets in the immunopathology of giant cell arteritis","volume":"7","author":"van Sleen","year":"2017","journal-title":"Sci Rep."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1136\/annrheumdis-2015-208371","article-title":"Blocking interferon \u03b3 reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis","volume":"75","author":"Corbera-Bellalta","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jaut.2016.05.008","article-title":"Involvement and prognosis value of CD8(+) T cells in giant cell arteritis","volume":"72","author":"Samson","year":"2016","journal-title":"J Autoimmun."},{"key":"B36","doi-asserted-by":"publisher","first-page":"654109","DOI":"10.3389\/fimmu.2021.654109","article-title":"CD8+ T cells in GCA and GPA: bystanders or active contributors?","volume":"12","author":"Reitsema","year":"2021","journal-title":"Front Immunol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"102684","DOI":"10.1016\/j.jaut.2021.102684","article-title":"Association of the CXCL9-CXCR3 and CXCL13-CXCR5 axes with B-cell trafficking in giant cell arteritis and polymyalgia rheumatica","volume":"123","author":"Graver","year":"2021","journal-title":"J Autoimmun."},{"key":"B38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fimmu.2019.00083","article-title":"Massive B-cell infiltration and organization into artery tertiary lymphoid organs in the aorta of large vessel giant cell arteritis","volume":"10","author":"Graver","year":"2019","journal-title":"Front Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"33.1","DOI":"10.1136\/annrheumdis-2021-eular.1984","article-title":"OP0062 cytokine producing B cells skew macrophages towards a pro-inflammatory phenotype in giant cell arteritis","volume":"80","author":"Graver","year":"2021","journal-title":"Ann Rheum Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1136\/annrheumdis-2021-220873","article-title":"Blocking GM-CSF receptor \u03b1 with mavrilimumab reduces infiltrating cells, pro-inflammatory markers and neoangiogenesis in ex vivo cultured arteries from patients with giant cell arteritis","volume":"81","author":"Corbera-Bellalta","year":"2022","journal-title":"Ann Rheum Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"e1164","DOI":"10.1002\/cti2.1164","article-title":"Distinct macrophage phenotypes skewed by local granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) are associated with tissue destruction and intimal hyperplasia in giant cell arteritis","volume":"9","author":"Jiemy","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1002\/art.41887","article-title":"Distinct macrophage subset mediating tissue destruction and neovascularization in giant cell arteritis: implication of the YKL-40\/interleukin-13 receptor \u03b12 axis","volume":"73","author":"van Sleen","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab814","article-title":"Plasma Pyruvate kinase M2 as a marker of vascular inflammation in giant cell arteritis","author":"Esen","year":"2021","journal-title":"Rheumatology."},{"key":"B44","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1002\/1529-0131(199912)42:12<2624::AID-ANR17>3.0.CO;2-K","article-title":"YKL-40 in giant cells and macrophages from patients with giant cell arteritis","volume":"42","author":"Johansen","year":"1999","journal-title":"Arthritis Rheum."},{"key":"B45","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1161\/CIRCRESAHA.118.313206","article-title":"MMP (matrix metalloprotease)-9-producing monocytes enable T cells to invade the vessel wall and cause vasculitis","volume":"123","author":"Watanabe","year":"2018","journal-title":"Circ Res."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1161\/01.RES.84.9.1050","article-title":"Tissue-destructive macrophages in giant cell arteritis","volume":"84","author":"Rittner","year":"1999","journal-title":"Circ Res."},{"key":"B47","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1136\/annrheumdis-2012-201309","article-title":"IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis","volume":"72","author":"Ciccia","year":"2013","journal-title":"Ann Rheum Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1172\/JCI118959","article-title":"Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis","volume":"98","author":"Weyand","year":"1996","journal-title":"J Clin Invest."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1136\/annrheumdis-2016-210792","article-title":"Endothelin-1 promotes vascular smooth muscle cell migration across the artery wall: a mechanism contributing to vascular remodelling and intimal hyperplasia in giant-cell arteritis","volume":"76","author":"Planas-Rigol","year":"2017","journal-title":"Ann Rheum Dis."},{"key":"B50","doi-asserted-by":"publisher","first-page":"151728","DOI":"10.1016\/j.anndiagpath.2021.151728","article-title":"An immunohistochemical analysis of fibroblasts in giant cell arteritis","volume":"52","author":"Parreau","year":"2021","journal-title":"Ann Diagn Pathol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"621098","DOI":"10.3389\/fimmu.2020.621098","article-title":"Innate and adaptive immunity in giant cell arteritis","volume":"11","author":"Akiyama","year":"2020","journal-title":"Front Immunol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1699-0463.1996.tb00707.x","article-title":"Atrophy of the aortic media in giant cell arteritis","volume":"104","author":"Petursdottir","year":"1996","journal-title":"APMIS."},{"key":"B53","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1136\/ard.23.6.447","article-title":"Polymyalgia rheumatica: biopsy studies","volume":"23","author":"Gordon","year":"1964","journal-title":"Ann Rheum Dis."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1002\/art.1780390719","article-title":"Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica. Quantitative analysis and influence of corticosteroid treatment","volume":"39","author":"Meliconi","year":"1996","journal-title":"Arthritis Rheum."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1002\/1529-0131(200011)43:11<2472::AID-ANR14>3.0.CO;2-B","article-title":"Vascular endothelial growth factor production in polymyalgia rheumatica","volume":"43","author":"Meliconi","year":"2000","journal-title":"Arthritis Rheum"},{"key":"B56","article-title":"Characterization of synovial fluid T cells in polymyalgia rheumatica: implication of Th1 and Tc1 effector memory profiles [abstract]","volume":"73","author":"Reitsema","year":"2021","journal-title":"Arthrit Rheumatol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13075-021-02457-3","article-title":"Phenotypic alteration of macrophages during osteoarthritis: a systematic review","volume":"23","author":"Zhu","year":"2021","journal-title":"Arthritis Res Ther."},{"key":"B58","doi-asserted-by":"publisher","first-page":"102397","DOI":"10.1016\/j.autrev.2019.102397","article-title":"Macrophage M1\/M2 polarization and rheumatoid arthritis: a systematic review","volume":"18","author":"Tardito","year":"2019","journal-title":"Autoimmun Rev."},{"key":"B59","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/modpathol.2017.10","article-title":"Clinical and pathological evolution of giant cell arteritis: a prospective study of follow-up temporal artery biopsies in 40 treated patients","volume":"30","author":"Maleszewski","year":"2017","journal-title":"Mod Pathol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s12891-016-1225-2","article-title":"The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis","volume":"17","author":"Jakobsson","year":"2016","journal-title":"BMC Musculoskelet Disord."},{"key":"B61","doi-asserted-by":"publisher","first-page":"768","DOI":"10.11909\/j.issn.1671-5411.2021.09.008","article-title":"Cellular signaling pathways of T cells in giant cell arteritis","volume":"18","author":"Li","year":"2021","journal-title":"J Geriatr Cardiol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s00259-012-2176-y","article-title":"Pharmacokinetic modelling of N-(4-[(18)F]fluorobenzoyl)interleukin-2 binding to activated lymphocytes in an xenograft model of inflammation","volume":"39","author":"Di Gialleonardo","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B63","doi-asserted-by":"publisher","first-page":"4369","DOI":"10.1007\/s00259-021-05407-y","article-title":"Interleukin-2 PET imaging in patients with metastatic melanoma before and during immune checkpoint inhibitor therapy","volume":"48","author":"van de Donk","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B64","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2967\/jnumed.111.091306","article-title":"N-(4-18F-fluorobenzoyl)interleukin-2 for PET of human-activated T lymphocytes","volume":"53","author":"Di Gialleonardo","year":"2012","journal-title":"J Nucl Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.2967\/jnumed.119.238782","article-title":"Development and evaluation of interleukin-2\u2013derived radiotracers for PET imaging of T cells in mice","volume":"61","author":"Van der Veen","year":"2020","journal-title":"J Nucl Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"799910","DOI":"10.3389\/fimmu.2021.799910","article-title":"Single-domain antibodies for targeting, detection, and in vivo imaging of human CD4+ cells","volume":"12","author":"Traenkle","year":"2021","journal-title":"Front Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1158\/1535-7163.MCT-21-0888","article-title":"Non-invasive imaging of CD4+ T cells in humanized mice","volume":"21","author":"Nagle","year":"2022","journal-title":"Mol Cancer Ther."},{"key":"B68","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s11307-021-01621-0","article-title":"Preclinical evaluation of 89 Zr-Df-IAB22M2C PET as an imaging biomarker for the development of the GUCY2C-CD3 bispecific PF-07062119 as a T cell engaging therapy","volume":"23","author":"Maresca","year":"2021","journal-title":"Mol Imaging Biol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1158\/0008-5472.CAN-19-3269","article-title":"The PET-tracer 89 Zr-Df-IAB22M2C enables monitoring of intratumoral CD8 T-cell infiltrates in tumor-bearing humanized mice after T-cell bispecific antibody treatment","volume":"80","author":"Griessinger","year":"2020","journal-title":"Cancer Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"720","DOI":"10.2967\/jnumed.121.262485","article-title":"CD8-targeted PET imaging of tumor infiltrating T cells in patients with cancer: a phase I first-in-human study of 89 Zr-Df-IAB22M2C, a radiolabeled anti-CD8 minibody","volume":"63","author":"Farwell","year":"2021","journal-title":"J Nucl Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"512","DOI":"10.2967\/jnumed.119.229781","article-title":"First-in-humans imaging with 89 Zr-Df-IAB22M2C anti-CD8 minibody in patients with solid malignancies: preliminary pharmacokinetics, biodistribution, and lesion targeting","volume":"61","author":"Pandit-Taskar","year":"2020","journal-title":"J Nucl Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/JLB.2RI0717-278R","article-title":"Biology of IL-2 and its therapeutic modulation: mechanisms and strategies","volume":"103","author":"Mitra","year":"2018","journal-title":"J Leukoc Biol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/acel.12353","article-title":"Low-affinity TCR engagement drives IL-2-dependent post-thymic maintenance of naive CD4+ T cells in aged humans","volume":"14","author":"van der Geest","year":"2015","journal-title":"Aging Cell."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1007\/s00259-008-0837-7","article-title":"99mTc-interleukin-2 scintigraphy in normal subjects and in patients with autoimmune thyroid diseases: a feasibility study","volume":"35","author":"Chianelli","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B75","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s13550-019-0511-z","article-title":"99m Tc-HYNIC-IL-2 scintigraphy to detect acute rejection in lung transplantation patients: a proof-of-concept study","volume":"9","author":"Telenga","year":"2019","journal-title":"EJNMMI Res."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1007\/s00259-014-2764-0","article-title":"In vivo and in vitro evidence that 99mTc-HYNIC-interleukin-2 is able to detect T lymphocytes in vulnerable atherosclerotic plaques of the carotid artery","volume":"41","author":"Glaudemans","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B77","first-page":"1225","article-title":"Diagnosis and followup of Takayasu's arteritis by scintigraphy with radiolabelled interleukin 2","volume":"31","author":"Lucia","year":"2004","journal-title":"J Rheumatol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cpet.2019.08.008","article-title":"Programmed cell death-1\/ligand-1 PET imaging: a novel tool to optimize immunotherapy?","volume":"15","author":"Verhoeff","year":"2020","journal-title":"PET Clin."},{"key":"B79","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3389\/fimmu.2018.00315","article-title":"Checks and balances in autoimmune vasculitis","volume":"9","author":"Cadena","year":"2018","journal-title":"Front Immunol."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217381","article-title":"Imaging in immune checkpoint inhibitor-induced polymyalgia rheumatica","author":"Van Der Geest","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2020.06.001","article-title":"Inhibitory receptor agonists: the future of autoimmune disease therapeutics?","volume":"67","author":"Grebinoski","year":"2020","journal-title":"Curr Opin Immunol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-17813-1","article-title":"PD-1 pathway regulates ILC2 metabolism and PD-1 agonist treatment ameliorates airway hyperreactivity","volume":"11","author":"Helou","year":"2020","journal-title":"Nat Commun."},{"key":"B83","doi-asserted-by":"publisher","first-page":"e2102164118","DOI":"10.1073\/pnas.2102164118","article-title":"Computational design of a synthetic PD-1 agonist","volume":"118","author":"Bryan","year":"2021","journal-title":"Proc Natl Acad Sci USA."},{"key":"B84","doi-asserted-by":"publisher","first-page":"e152468","DOI":"10.1172\/jci.insight.152468","article-title":"Cell-targeted PD-1 agonists that mimic PD-L1 are potent T cell inhibitors","volume":"6","author":"Curnock","year":"2021","journal-title":"JCI Insight."},{"key":"B85","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1161\/01.CIR.73.3.476","article-title":"Peripheral-type benzodiazepine receptors in the living heart characterized by positron emission tomography","volume":"73","author":"Charbonneau","year":"1986","journal-title":"Circulation."},{"key":"B86","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/BF03164587","article-title":"Synthesis and evaluation of 11C-PK 11195 for in vivo study of peripheral-type benzodiazepine receptors using positron emission tomography","volume":"3","author":"Hashimoto","year":"1989","journal-title":"Ann Nucl Med."},{"key":"B87","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1097\/00001756-200009110-00025","article-title":"In vivo imaging of activated microglia using [11C]PK11195 and positron emission tomography in patients after ischemic stroke","volume":"11","author":"Gerhard","year":"2000","journal-title":"Neuroreport."},{"key":"B88","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1093\/eurheartj\/ehr367","article-title":"Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography\/computed tomography","volume":"33","author":"Gaemperli","year":"2012","journal-title":"Eur Heart J."},{"key":"B89","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ijcha.2018.09.005","article-title":"Carotid artery plaque uptake of 11 C-PK11195 inversely correlates with circulating monocytes and classical CD14 ++ CD16 - monocytes expressing HLA-DR","volume":"21","author":"Ammirati","year":"2018","journal-title":"Int J Cardiol Hear Vasc."},{"key":"B90","doi-asserted-by":"publisher","first-page":"e2761","DOI":"10.1212\/WNL.0000000000012033","article-title":"[11C]PK11195-PET brain imaging of the mitochondrial translocator protein in mitochondrial disease","volume":"96","author":"van den Ameele","year":"2021","journal-title":"Neurology."},{"key":"B91","first-page":"127","article-title":"Semiquantification of the peripheral-type benzodiazepine ligand [11C]PK11195 in normal human brain and application in multiple sclerosis patients","volume":"102","author":"Debruyne","year":"2002","journal-title":"Acta Neurol Belg."},{"key":"B92","first-page":"2207","article-title":"PET of peripheral benzodiazepine binding sites in the microgliosis of Alzheimer's disease","volume":"36","author":"Groom","year":"1995","journal-title":"J Nucl Med."},{"key":"B93","first-page":"1608","article-title":"study of carbon-11-PK 11195 binding to peripheral type benzodiazepine sites in glioblastoma: a case report","volume":"32","author":"Pappata","year":"1991","journal-title":"J Nucl Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.jacc.2010.02.063","article-title":"Imaging of vascular inflammation with [11C]-PK11195 and positron emission tomography\/computed tomography angiography","volume":"56","author":"Pugliese","year":"2010","journal-title":"J Am Coll Cardiol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/0969-8051(94)90022-1","article-title":"Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats","volume":"21","author":"Shah","year":"1994","journal-title":"Nucl Med Biol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1212\/WNL.53.9.2199","article-title":"[11C](R)-PK11195 positron emission tomography imaging of activated microglia in vivo in Rasmussen's encephalitis","volume":"53","author":"Banati","year":"1999","journal-title":"Neurology."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","article-title":"Microglial activation correlates with severity in Huntington disease: a clinical and PET study","volume":"66","author":"Pavese","year":"2006","journal-title":"Neurology."},{"key":"B98","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1002\/art.23955","article-title":"Noninvasive imaging of macrophages in rheumatoid synovitis using 11C-(R)-PK11195 and positron emission tomography","volume":"58","author":"Van Der Laken","year":"2008","journal-title":"Arthritis Rheum."},{"key":"B99","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1007\/s00259-008-0987-7","article-title":"Quantification of (R)-[11C]PK11195 binding in rheumatoid arthritis","volume":"36","author":"Kropholler","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B100","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/art.30655","article-title":"Macrophage positron emission tomography imaging as a biomarker for preclinical rheumatoid arthritis: findings of a prospective pilot study","volume":"64","author":"Gent","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B101","doi-asserted-by":"publisher","first-page":"945","DOI":"10.2967\/jnumed.113.131045","article-title":"Neuroinflammation in patients with chronic fatigue syndrome\/myalgic encephalomyelitis: an 11C-(R)-PK11195 PET study","volume":"55","author":"Nakatomi","year":"2014","journal-title":"J Nucl Med."},{"key":"B102","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.bbi.2014.03.016","article-title":"Neuroinflammation in bipolar disorder - A [(11)C]-(R)-PK11195 positron emission tomography study","volume":"40","author":"Haarman","year":"2014","journal-title":"Brain Behav Immun."},{"key":"B103","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13075-015-0770-7","article-title":"Subclinical synovitis detected by macrophage PET, but not MRI, is related to short-term flare of clinical disease activity in early RA patients: an exploratory study","volume":"17","author":"Gent","year":"2015","journal-title":"Arthritis Res Ther."},{"key":"B104","doi-asserted-by":"publisher","first-page":"e5735","DOI":"10.1097\/MD.0000000000005735","article-title":"[11C]-(R)-PK11195 positron emission tomography in patients with complex regional pain syndrome: a pilot study","volume":"96","author":"Jeon","year":"2017","journal-title":"Medicine."},{"key":"B105","doi-asserted-by":"publisher","first-page":"0246152","DOI":"10.1371\/journal.pone.0246152","article-title":"Abnormal neuroinflammation in fibromyalgia and CRPS using [11C]-(R)-PK11195 PET","volume":"16","author":"Seo","year":"2021","journal-title":"PLoS ONE."},{"key":"B106","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2967\/jnumed.110.079038","article-title":"Detection and quantification of large-vessel inflammation with 11C-(R)-PK11195 PET\/CT","volume":"52","author":"Lamare","year":"2011","journal-title":"J Nucl Med."},{"key":"B107","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1093\/brain\/123.11.2321","article-title":"The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity","volume":"123","author":"Banati","year":"2000","journal-title":"Brain."},{"key":"B108","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1093\/brain\/124.10.2014","article-title":"In vivo visualization of activated glia by [11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion","volume":"124","author":"Cagnin","year":"2001","journal-title":"Brain."},{"key":"B109","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1212\/01.WNL.0000078192.95645.E6","article-title":"[11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy","volume":"61","author":"Gerhard","year":"2003","journal-title":"Neurology."},{"key":"B110","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.nbd.2003.12.012","article-title":"Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study","volume":"15","author":"Turner","year":"2004","journal-title":"Neurobiol Dis."},{"key":"B111","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.neuroimage.2004.09.034","article-title":"Evolution of microglial activation in patients after ischemic stroke: a [11C](R)-PK11195 PET study","volume":"24","author":"Gerhard","year":"2005","journal-title":"Neuroimage."},{"key":"B112","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1080\/13550280500187351","article-title":"Imaging glial cell activation with [11C]-R-PK11195 in patients with AIDS","volume":"11","author":"Hammoud","year":"2005","journal-title":"J Neurovirol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease","volume":"21","author":"Gerhard","year":"2006","journal-title":"Neurobiol Dis."},{"key":"B114","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1136\/gut.2005.075051","article-title":"In vivo imaging of cerebral \u201cperipheral benzodiazepine binding sites\u201d in patients with hepatic encephalopathy","volume":"55","author":"Cagnin","year":"2006","journal-title":"Gut."},{"key":"B115","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1007\/s00213-018-5077-3","article-title":"Effect of overnight smoking abstinence on a marker for microglial activation: a [11 C]DAA1106 positron emission tomography study","volume":"235","author":"Brody","year":"2018","journal-title":"Psychopharmacology."},{"key":"B116","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.nucmedbio.2014.07.004","article-title":"Radiation dosimetry and biodistribution of the translocator protein radiotracer [(11)C]DAA1106 determined with PET\/CT in healthy human volunteers","volume":"41","author":"Brody","year":"2014","journal-title":"Nucl Med Biol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.pscychresns.2011.08.013","article-title":"Increased binding of peripheral benzodiazepine receptor in mild cognitive impairment-dementia converters measured by positron emission tomography with [11C]DAA1106","volume":"203","author":"Yasuno","year":"2012","journal-title":"Psychiatry Res."},{"key":"B118","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1017\/S1461145710000313","article-title":"Peripheral benzodiazepine receptors in patients with chronic schizophrenia: a PET study with [11C]DAA1106","volume":"13","author":"Takano","year":"2010","journal-title":"Int J Neuropsychopharmacol."},{"key":"B119","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.biopsych.2008.04.021","article-title":"Increased binding of peripheral benzodiazepine receptor in Alzheimer's disease measured by positron emission tomography with [11C]DAA1106","volume":"64","author":"Yasuno","year":"2008","journal-title":"Biol Psychiatry."},{"key":"B120","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/sj.jcbfm.9600325","article-title":"Quantitative analysis for estimating binding potential of the peripheral benzodiazepine receptor with [(11)C]DAA1106","volume":"27","author":"Ikoma","year":"2007","journal-title":"J Cereb Blood Flow Metab."},{"key":"B121","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0969-8051(03)00016-7","article-title":"[(11)C]DAA1106: radiosynthesis and in vivo binding to peripheral benzodiazepine receptors in mouse brain","volume":"30","author":"Zhang MR Kida","year":"2003","journal-title":"Nucl Med Biol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1097\/SHK.0000000000001546","article-title":"Positron emission tomography imaging of long-term expression of the 18 kDa translocator protein after sudden cardiac arrest in rats","volume":"55","author":"Schroeder","year":"2021","journal-title":"Shock."},{"key":"B123","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.apradiso.2012.03.011","article-title":"Fully automated synthesis of PET TSPO radioligands [11C]DAA1106 and [18F]FEDAA1106","volume":"70","author":"Wang","year":"2012","journal-title":"Appl Radiat Isot."},{"key":"B124","doi-asserted-by":"publisher","first-page":"4817","DOI":"10.1016\/j.bmc.2018.08.017","article-title":"[18 F]DAA1106: automated radiosynthesis using spirocyclic iodonium ylide and preclinical evaluation for positron emission tomography imaging of translocator protein (18 kDa)","volume":"26","author":"Kumata","year":"2018","journal-title":"Bioorg Med Chem."},{"key":"B125","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0960-894X(02)00886-7","article-title":"[18F]FMDAA1106 and [18F]FEDAA1106: two positron-emitter labeled ligands for peripheral benzodiazepine receptor (PBR)","volume":"13","author":"Zhang","year":"2003","journal-title":"Bioorg Med Chem Lett."},{"key":"B126","first-page":"43","article-title":"Quantitative analyses of 18F-FEDAA1106 binding to peripheral benzodiazepine receptors in living human brain","volume":"47","author":"Fujimura","year":"2006","journal-title":"J Nucl Med."},{"key":"B127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2310\/7290.2014.00014","article-title":"In vivo mapping of vascular inflammation using the translocator protein tracer 18F-FEDAA1106","volume":"13","author":"Cuhlmann","year":"2014","journal-title":"Mol Imaging."},{"key":"B128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2191-219X-3-30","article-title":"In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106","volume":"3","author":"Takano","year":"2013","journal-title":"EJNMMI Res."},{"key":"B129","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00259-013-2359-1","article-title":"In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer's disease patients","volume":"40","author":"Varrone","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B130","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1007\/s00259-011-1864-3","article-title":"Biodistribution and radiation dosimetry of the 18 kDa translocator protein (TSPO) radioligand [18F]FEDAA1106: a human whole-body PET study","volume":"38","author":"Takano","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B131","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1093\/brain\/awab057","article-title":"Neuroinflammation is highest in areas of disease progression in semantic dementia","volume":"144","author":"Pascual","year":"2021","journal-title":"Brain."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3233\/JAD-201149","article-title":"Olfactory impairment is related to tau pathology and neuroinflammation in Alzheimer's disease","volume":"80","author":"Klein","year":"2021","journal-title":"J Alzheimers Dis."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.2967\/jnumed.116.175083","article-title":"Evidence of brain inflammation in patients with human T-lymphotropic virus type 1-associated myelopathy (HAM): a pilot, multimodal imaging study using 11C-PBR28 PET, MR T1-weighted, and diffusion-weighted imaging","volume":"57","author":"Dimber","year":"2016","journal-title":"J Nucl Med."},{"key":"B134","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00259-015-3043-4","article-title":"(11)C-PBR28 imaging in multiple sclerosis patients and healthy controls: test-retest reproducibility and focal visualization of active white matter areas","volume":"42","author":"Park","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B135","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neuroimage.2007.11.011","article-title":"Kinetic analysis in healthy humans of a novel positron emission tomography radioligand to image the peripheral benzodiazepine receptor, a potential biomarker for inflammation","volume":"40","author":"Fujita","year":"2008","journal-title":"Neuroimage."},{"key":"B136","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.2967\/jnumed.107.044842","article-title":"Radiation dosimetry and biodistribution in monkey and man of 11C-PBR28: a PET radioligand to image inflammation","volume":"48","author":"Brown","year":"2007","journal-title":"J Nucl Med."},{"key":"B137","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.neulet.2006.09.093","article-title":"PET imaging with [11C]PBR28 can localize and quantify upregulated peripheral benzodiazepine receptors associated with cerebral ischemia in rat","volume":"411","author":"Imaizumi","year":"2007","journal-title":"Neurosci Lett."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1536012120968669","article-title":"[11 C]Methionine and [11 C]PBR28 as PET imaging tracers to differentiate metastatic tumor recurrence or radiation necrosis","volume":"19","author":"Tran","year":"2020","journal-title":"Mol Imaging."},{"key":"B139","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/QAI.0000000000002435","article-title":"Comparison of [11C]-PBR28 binding between persons living with HIV and HIV-uninfected individuals","volume":"85","author":"Boerwinkle","year":"2020","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B140","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1093\/brain\/awy188","article-title":"Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease","volume":"141","author":"Dani","year":"2018","journal-title":"Brain."},{"key":"B141","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1002\/ana.25251","article-title":"Integrated magnetic resonance imaging and [11 C]-PBR28 positron emission tomographic imaging in amyotrophic lateral sclerosis","volume":"83","author":"Alshikho","year":"2018","journal-title":"Ann Neurol."},{"key":"B142","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1021\/acschemneuro.8b00072","article-title":"Neuroinflammation in Huntington's disease: new insights with 11 C-PBR28 PET\/MRI","volume":"9","author":"Lois","year":"2018","journal-title":"ACS Chem Neurosci."},{"key":"B143","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.nicl.2017.10.024","article-title":"Imaging of glia activation in people with primary lateral sclerosis","volume":"17","author":"Paganoni","year":"2017","journal-title":"NeuroImage Clin."},{"key":"B144","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s11307-017-1129-z","article-title":"Imaging of human brown adipose tissue with the TSPO Tracer [11 C]PBR28","volume":"20","author":"Ran","year":"2018","journal-title":"Mol Imaging Biol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1177\/0271678X17712388","article-title":"Kinetic modelling of [11 C]PBR28 for 18 kDa translocator protein PET data: a validation study of vascular modelling in the brain using XBD173 and tissue analysis","volume":"38","author":"Veronese","year":"2018","journal-title":"J Cereb Blood Flow Metab."},{"key":"B146","doi-asserted-by":"publisher","first-page":"e289","DOI":"10.1097\/RLU.0000000000002179","article-title":"18F-PBR06 versus 11C-PBR28 PET for assessing white matter translocator protein binding in multiple sclerosis","volume":"43","author":"Singhal","year":"2018","journal-title":"Clin Nucl Med."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.steroids.2011.06.012","article-title":"Synthesis of [11C]PBR06 and [18F]PBR06 as agents for positron emission tomographic (PET) imaging of the translocator protein (TSPO)","volume":"76","author":"Wang","year":"2011","journal-title":"Steroids."},{"key":"B148","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1007\/s00259-010-1622-y","article-title":"Comparison of 18F- and 11C-labeled aryloxyanilide analogs to measure translocator protein in human brain using positron emission tomography","volume":"38","author":"Dickstein","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B149","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2967\/jnumed.109.068064","article-title":"Biodistribution and radiation dosimetry in humans of a new PET ligand, (18)F-PBR06, to image translocator protein (18 kDa)","volume":"51","author":"Fujimura","year":"2010","journal-title":"J Nucl Med."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2967\/jnumed.108.060186","article-title":"Quantification of translocator protein (18 kDa) in the human brain with PET and a novel radioligand, (18)F-PBR06","volume":"50","author":"Fujimura","year":"2009","journal-title":"J Nucl Med."},{"key":"B151","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/syn.20394","article-title":"Kinetic evaluation in nonhuman primates of two new PET ligands for peripheral benzodiazepine receptors in brain","volume":"61","author":"Imaizumi","year":"2007","journal-title":"Synapse."},{"key":"B152","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1021\/jm0707370","article-title":"Synthesis and evaluation in monkey of two sensitive 11C-labeled aryloxyanilide ligands for imaging brain peripheral benzodiazepine receptors in vivo","volume":"51","author":"Briard","year":"2008","journal-title":"J Med Chem"},{"key":"B153","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.nucmedbio.2007.12.009","article-title":"Radiosynthesis and initial evaluation of [18F]-FEPPA for PET imaging of peripheral benzodiazepine receptors","volume":"35","author":"Wilson","year":"2008","journal-title":"Nucl Med Biol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1038\/jcbfm.2011.55","article-title":"Quantitation of translocator protein binding in human brain with the novel radioligand [18F]-FEPPA and positron emission tomography","volume":"31","author":"Rusjan","year":"2011","journal-title":"J Cereb Blood Flow Metab."},{"key":"B155","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1002\/syn.21765","article-title":"Quantitative imaging of neuroinflammation in human white matter: a positron emission tomography study with translocator protein 18 kDa radioligand, [18F]-FEPPA","volume":"68","author":"Suridjan","year":"2014","journal-title":"Synapse."},{"key":"B156","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s11307-012-0589-4","article-title":"Whole body biodistribution and radiation dosimetry in humans of a new PET ligand, [(18)F]-FEPPA, to image translocator protein (18 kDa)","volume":"15","author":"Mizrahi","year":"2013","journal-title":"Mol imaging Biol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.neuroimage.2013.09.021","article-title":"Neuroinflammation in healthy aging: a PET study using a novel Translocator Protein 18kDa (TSPO) radioligand, [(18)F]-FEPPA","volume":"84","author":"Suridjan","year":"2014","journal-title":"Neuroimage."},{"key":"B158","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/schbul\/sbu157","article-title":"Imaging neuroinflammation in gray and white matter in schizophrenia: an in-vivo PET study with [18F]-FEPPA","volume":"41","author":"Kenk","year":"2015","journal-title":"Schizophr Bull."},{"key":"B159","first-page":"1579","article-title":"In-vivo imaging of grey and white matter neuroinflammation in Alzheimer's disease: a positron emission tomography study with a novel radioligand, [18F]-FEPPA","volume-title":"Mol Psychiatry.","author":"Suridjan","year":"2015"},{"key":"B160","doi-asserted-by":"publisher","first-page":"138721","DOI":"10.1371\/journal.pone.0138721","article-title":"Imaging striatal microglial activation in patients with Parkinson's Disease","volume":"10","author":"Koshimori","year":"2015","journal-title":"PLoS ONE."},{"key":"B161","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1176\/appi.ajp.2016.16020171","article-title":"Imaging microglial activation in untreated first-episode psychosis: a PET study with [18 F]FEPPA","volume":"174","author":"Hafizi","year":"2017","journal-title":"Am J Psychiatry."},{"key":"B162","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1001\/jamapsychiatry.2017.1567","article-title":"Inflammation in the neurocircuitry of obsessive-compulsive disorder","volume":"74","author":"Attwells","year":"2017","journal-title":"JAMA Psychiatry."},{"key":"B163","doi-asserted-by":"publisher","first-page":"e12876","DOI":"10.1111\/adb.12876","article-title":"Microglia imaging in methamphetamine use disorder: a positron emission tomography study with the 18 kDa translocator protein radioligand [F-18]FEPPA","volume":"26","author":"Rathitharan","year":"2021","journal-title":"Addict Biol."},{"key":"B164","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.2967\/jnumed.117.203315","article-title":"18 F-PBR111 PET imaging in healthy controls and schizophrenia: test-retest reproducibility and quantification of neuroinflammation","volume":"59","author":"Ottoy","year":"2018","journal-title":"J Nucl Med."},{"key":"B165","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.2967\/jnumed.113.121020","article-title":"Quantification of the specific translocator protein signal of 18F-PBR111 in healthy humans: a genetic polymorphism effect on in vivo binding","volume":"54","author":"Guo","year":"2013","journal-title":"J Nucl Med."},{"key":"B166","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.apradiso.2011.07.014","article-title":"Automated radiosynthesis of [18F]PBR111 and [18F]PBR102 using the Tracerlab FXFN and Tracerlab MXFDG module for imaging the peripheral benzodiazepine receptor with PET","volume":"70","author":"Bourdier","year":"2012","journal-title":"Appl Radiat Isot."},{"key":"B167","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1007\/s00259-009-1353-0","article-title":"In vivo imaging of neuroinflammation: a comparative study between [(18)F]PBR111, [(11)C]CLINME and [(11)C]PK11195 in an acute rodent model","volume":"37","author":"Van Camp","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B168","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.2967\/jnumed.116.187161","article-title":"11 C-PBR28 and 18 F-PBR111 detect white matter inflammatory heterogeneity in multiple sclerosis","volume":"58","author":"Datta","year":"2017","journal-title":"J Nucl Med."},{"key":"B169","doi-asserted-by":"publisher","first-page":"3700","DOI":"10.1021\/jm7014556","article-title":"Synthesis and biological evaluation of substituted [18F]imidazo[1,2-a]pyridines and [18F]pyrazolo[1,5-a]pyrimidines for the study of the peripheral benzodiazepine receptor using positron emission tomography","volume":"51","author":"Fookes","year":"2008","journal-title":"J Med Chem."},{"key":"B170","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.nucmedbio.2011.11.003","article-title":"Radiation dosimetry of the translocator protein ligands [18F]PBR111 and [18F]PBR102","volume":"39","author":"Verschuer","year":"2012","journal-title":"Nucl Med Biol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1097\/RLU.0000000000001936","article-title":"Microglial activation on 11C-CB184 PET in a patient with cerebellar ataxia associated with HIV infection","volume":"43","author":"Ishibashi","year":"2018","journal-title":"Clin Nucl Med."},{"key":"B172","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13550-017-0271-6","article-title":"Assessment of safety, efficacy, and dosimetry of a novel 18-kDa translocator protein ligand, [11 C]CB184, in healthy human volunteers","volume":"7","author":"Sakata","year":"2017","journal-title":"EJNMMI Res."},{"key":"B173","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s12149-016-1094-7","article-title":"Preclinical and first-in-man studies of [(11)C]CB184 for imaging the 18-kDa translocator protein by positron emission tomography","volume":"30","author":"Toyohara","year":"2016","journal-title":"Ann Nucl Med."},{"key":"B174","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s12149-015-0948-8","article-title":"Radiosynthesis and in vivo evaluation of two imidazopyridineacetamides, [(11)C]CB184 and [(11)C]CB190, as a PET tracer for 18 kDa translocator protein: direct comparison with [(11)C](R)-PK11195","volume":"29","author":"Hatano","year":"2015","journal-title":"Ann Nucl Med."},{"key":"B175","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1002\/glia.20562","article-title":"In vivo imaging of brain lesions with [(11)C]CLINME, a new PET radioligand of peripheral benzodiazepine receptors","volume":"55","author":"Boutin","year":"2007","journal-title":"Glia."},{"key":"B176","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.2174\/138161208786549443","article-title":"PET imaging of the peripheral benzodiazepine receptor: monitoring disease progression and therapy response in neurodegenerative disorders","volume":"14","author":"Doorduin","year":"2008","journal-title":"Curr Pharm Des."},{"key":"B177","doi-asserted-by":"publisher","first-page":"20422","DOI":"10.1038\/srep20422","article-title":"A novel PET imaging probe for the detection and monitoring of translocator protein 18 kDa expression in pathological disorders","volume":"6","author":"Perrone","year":"2016","journal-title":"Sci Rep."},{"key":"B178","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3390\/ijms19010276","article-title":"Assessment of TSPO in a rat experimental autoimmune myocarditis model: a comparison study between [18 F]fluoromethyl-PBR28 and [18 F]CB251","volume":"19","author":"Kim","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B179","doi-asserted-by":"publisher","first-page":"9315","DOI":"10.7150\/thno.46875","article-title":"[18 F]CB251 PET\/MR imaging probe targeting translocator protein (TSPO) independent of its polymorphism in a neuroinflammation model","volume":"10","author":"Kim","year":"2020","journal-title":"Theranostics."},{"key":"B180","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.nucmedbio.2006.08.004","article-title":"Blood flow dependence of the intratumoral distribution of peripheral benzodiazepine receptor binding in intact mouse fibrosarcoma","volume":"33","author":"Amitani","year":"2006","journal-title":"Nucl Med Biol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.neuroimage.2010.08.010","article-title":"Visualization of early infarction in rat brain after ischemia using a translocator protein (18 kDa) PET ligand [11C]DAC with ultra-high specific activity","volume":"54","author":"Yui","year":"2011","journal-title":"Neuroimage."},{"key":"B182","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/syn.20678","article-title":"Evaluation of N-benzyl-N-[11C]methyl-2- (7-methyl-8-oxo-2-phenyl-7,8-dihydro-9H-purin-9-yl)acetamide ([11C]DAC) as a novel translocator protein (18 kDa) radioligand in kainic acid-lesioned rat","volume":"63","author":"Yanamoto","year":"2009","journal-title":"Synapse."},{"key":"B183","doi-asserted-by":"publisher","first-page":"6188","DOI":"10.1016\/j.bmc.2005.06.030","article-title":"Synthesis and in vivo evaluation of a novel peripheral benzodiazepine receptor PET radioligand","volume":"13","author":"James","year":"2005","journal-title":"Bioorg Med Chem."},{"key":"B184","doi-asserted-by":"publisher","first-page":"573","DOI":"10.2967\/jnumed.106.036764","article-title":"11C-DPA-713: a novel peripheral benzodiazepine receptor PET ligand for in vivo imaging of neuroinflammation","volume":"48","author":"Boutin","year":"2007","journal-title":"J Nucl Med."},{"key":"B185","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.3390\/ijms21093137","article-title":"Quantitative assessment of arthritis activity in rheumatoid arthritis patients using [11 C]DPA-713 positron emission tomography","volume":"21","author":"Yaqub","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B186","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.2967\/jnumed.109.062265","article-title":"Initial evaluation of 11C-DPA-713, a novel TSPO PET ligand, in humans","volume":"50","author":"Endres","year":"2009","journal-title":"J Nucl Med."},{"key":"B187","doi-asserted-by":"publisher","first-page":"330","DOI":"10.2967\/jnumed.111.094565","article-title":"Radiation dosimetry and biodistribution of the TSPO ligand 11C-DPA-713 in humans","volume":"53","author":"Endres","year":"2012","journal-title":"J Nucl Med."},{"key":"B188","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s13365-014-0239-5","article-title":"Regional brain distribution of translocator protein using [(11)C]DPA-713 PET in individuals infected with HIV","volume":"20","author":"Coughlin","year":"2014","journal-title":"J Neurovirol."},{"key":"B189","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/tp.2016.40","article-title":"In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [(11)C]DPA-713 PET and analysis of CSF and plasma","volume":"6","author":"Coughlin","year":"2016","journal-title":"Transl Psychiatry."},{"key":"B190","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1177\/0961203316657432","article-title":"Neuroimaging of translocator protein in patients with systemic lupus erythematosus: a pilot study using [11 C]DPA-713 positron emission tomography","volume":"26","author":"Wang","year":"2017","journal-title":"Lupus."},{"key":"B191","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1097\/QAD.0000000000001858","article-title":"Microglial activation is inversely associated with cognition in individuals living with HIV on effective antiretroviral therapy","volume":"32","author":"Rubin","year":"2018","journal-title":"AIDS."},{"key":"B192","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12974-018-1381-4","article-title":"Imaging glial activation in patients with post-treatment Lyme disease symptoms: a pilot study using [11 C]DPA-713 PET","volume":"82","author":"Coughlin","year":"2018","journal-title":"J Neuroinflamm."},{"key":"B193","doi-asserted-by":"publisher","first-page":"222844","DOI":"10.1371\/journal.pone.0222844","article-title":"Imaging disease activity of rheumatoid arthritis by macrophage targeting using second generation translocator protein positron emission tomography tracers","volume":"14","author":"Bruijnen","year":"2019","journal-title":"PLoS ONE."},{"key":"B194","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.parkreldis.2020.11.011","article-title":"Increased microglial activation in patients with Parkinson disease using [18 F]-DPA714 TSPO PET imaging","volume":"82","author":"Lavisse","year":"2021","journal-title":"Parkinsonism Relat Disord."},{"key":"B195","doi-asserted-by":"publisher","first-page":"814","DOI":"10.2967\/jnumed.107.046151","article-title":"DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization","volume":"49","author":"James","year":"2008","journal-title":"J Nucl Med."},{"key":"B196","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/jlcr.3199","article-title":"[18F]DPA-C5yne, a novel fluorine-18-labelled analogue of DPA-714: radiosynthesis and preliminary evaluation as a radiotracer for imaging neuroinflammation with PET","volume":"57","author":"M\u00e9dran-Navarrete","year":"2014","journal-title":"J Labelled Comp Radiopharm."},{"key":"B197","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s11307-021-01646-5","article-title":"Direct comparison of [18 F]F-DPA with [18 F]DPA-714 and [11 C]PBR28 for neuroinflammation imaging in the same Alzheimer's disease model mice and healthy controls","volume":"24","author":"L\u00f3pez-Pic\u00f3n","year":"2022","journal-title":"Mol imaging Biol."},{"key":"B198","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75705-2","article-title":"Automated synthesis and preliminary evaluation of [18 F]FDPA for cardiac inflammation imaging in rats after myocardial infarction","author":"Mou","year":"2020","journal-title":"Sci Rep."},{"key":"B199","doi-asserted-by":"publisher","first-page":"5222","DOI":"10.1021\/acs.jmedchem.7b00432","article-title":"A facile radiolabeling of [18 F]FDPA via spirocyclic iodonium ylides: preliminary PET imaging studies in preclinical models of neuroinflammation","volume":"60","author":"Wang","year":"2017","journal-title":"J Med Chem."},{"key":"B200","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1007\/s11307-016-1040-z","article-title":"Radiosynthesis and preclinical evaluation of [18 F]F-DPA, a novel pyrazolo[1,5a]pyrimidine acetamide TSPO radioligand, in healthy sprague dawley rats","volume":"19","author":"Keller","year":"2017","journal-title":"Mol imaging Biol."},{"key":"B201","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmech.2018.02.076","article-title":"Evaluation of the novel TSPO radiotracer 2-(7-butyl-2-(4-(2-([18 F]fluoroethoxy)phenyl)-5-methylpyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide in a preclinical model of neuroinflammation","volume":"150","author":"Tang","year":"2018","journal-title":"Eur J Med Chem."},{"key":"B202","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11307-018-1198-7","article-title":"Preclinical evaluation of a Novel TSPO PET Ligand 2-(7-Butyl-2-(4-(2-[18 F]Fluoroethoxy)phenyl)-5-Methylpyrazolo[1,5-a]Pyrimidin-3-yl)-N,N-Diethylacetamide (18 F-VUIIS1018A) to Image Glioma","volume":"21","author":"Tang","year":"2019","journal-title":"Mol imaging Biol."},{"key":"B203","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1016\/j.bmcl.2009.01.093","article-title":"[18F]FEAC and [18F]FEDAC: two novel positron emission tomography ligands for peripheral-type benzodiazepine receptor in the brain","volume":"19","author":"Yanamoto","year":"2009","journal-title":"Bioorg Med Chem Lett."},{"key":"B204","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.atherosclerosis.2021.10.003","article-title":"Translocator protein imaging with 18 F-FEDAC-positron emission tomography in rabbit atherosclerosis and its presence in human coronary vulnerable plaques","volume":"337","author":"Maekawa","year":"2021","journal-title":"Atherosclerosis."},{"key":"B205","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2967\/jnumed.117.200667","article-title":"18 F-FEDAC as a targeting agent for activated macrophages in DBA\/1 mice with collagen-induced arthritis: comparison with 18 F-FDG","volume":"59","author":"Chung","year":"2018","journal-title":"J Nucl Med."},{"key":"B206","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00259-010-1628-5","article-title":"In vivo imaging of neuroinflammation in the rodent brain with [11C]SSR180575, a novel indoleacetamide radioligand of the translocator protein (18 kDa)","volume":"38","author":"Chauveau","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B207","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.ejmech.2015.07.033","article-title":"Synthesis and in vitro characterization of novel fluorinated derivatives of the TSPO 18 kDa ligand SSR180575","volume":"101","author":"Damont","year":"2015","journal-title":"Eur J Med Chem."},{"key":"B208","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/mds.28825","article-title":"Neuroinflammation in the cerebellum and brainstem in Friedreich Ataxia: an [18F]-FEMPA PET Study","volume":"37","author":"Khan","year":"2022","journal-title":"Mov Disord."},{"key":"B209","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1007\/s12350-016-0527-y","article-title":"18-kDa translocator protein ligand 18 F-FEMPA: biodistribution and uptake into atherosclerotic plaques in mice","volume":"24","author":"Hellberg","year":"2017","journal-title":"J Nucl Cardiol."},{"key":"B210","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1007\/s00259-014-2955-8","article-title":"Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer's disease patients and control subjects","volume":"42","author":"Varrone","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B211","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.3390\/molecules26082372","article-title":"Fully automated synthesis of novel TSPO PET imaging ligand [18 F]Fluoroethyltemazepam","volume":"26","author":"Fiorenza","year":"2021","journal-title":"Molecules."},{"key":"B212","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1177\/0271678X21992457","article-title":"Detection of Alzheimer's disease-related neuroinflammation by a PET ligand selective for glial versus vascular translocator protein","volume":"41","author":"Ji","year":"2021","journal-title":"J Cereb Blood Flow Metab."},{"key":"B213","doi-asserted-by":"publisher","first-page":"961","DOI":"10.7150\/thno.12027","article-title":"[18F]FEBMP: positron emission tomography imaging of TSPO in a model of neuroinflammation in rats, and in vitro autoradiograms of the human brain","volume":"5","author":"Tiwari AK Ji","year":"2015","journal-title":"Theranostics."},{"key":"B214","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/s41409-022-01571-3","article-title":"[18 F]GE-180 PET\/CT assessment of enterocytic translocator protein (TSPO) over-expression: a pilot study in gastrointestinal GVHD","volume":"57","author":"Scott","year":"2022","journal-title":"Bone Marrow Transplant."},{"key":"B215","doi-asserted-by":"publisher","first-page":"9186902","DOI":"10.1155\/2018\/9186902","article-title":"Positron emission tomography imaging of macrophages in atherosclerosis with 18 F-GE-180, a radiotracer for translocator protein (TSPO)","volume":"2018","author":"Hellberg","year":"2018","journal-title":"Contrast Media Mol Imaging."},{"key":"B216","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.2967\/jnumed.117.203109","article-title":"Head-to-head comparison of 11 C-PBR28 and 18 F-GE180 for quantification of the translocator protein in the human brain","volume":"59","author":"Zanotti-Fregonara","year":"2018","journal-title":"J Nucl Med."},{"key":"B217","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13550-017-0340-x","article-title":"TSPO imaging using the novel PET ligand [18 F]GE-180: quantification approaches in patients with multiple sclerosis","volume":"7","author":"Vomacka","year":"2017","journal-title":"EJNMMI Res."},{"key":"B218","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.2967\/jnumed.115.169078","article-title":"Flutriciclamide (18F-GE180) PET: first-in-human PET study of novel third-generation in vivo marker of human translocator protein","volume":"57","author":"Fan","year":"2016","journal-title":"J Nucl Med."},{"key":"B219","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1007\/s00259-016-3444-z","article-title":"Kinetic analysis of the translocator protein positron emission tomography ligand [18 F]GE-180 in the human brain","volume":"43","author":"Feeney","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B220","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1016\/j.bmcl.2011.12.084","article-title":"[18F]GE-180: a novel fluorine-18 labelled PET tracer for imaging Translocator protein 18 kDa (TSPO)","volume":"22","author":"Wadsworth","year":"2012","journal-title":"Bioorg Med Chem Lett."},{"key":"B221","doi-asserted-by":"publisher","first-page":"484","DOI":"10.20944\/preprints202104.0548.v1","article-title":"Impact of TSPO receptor polymorphism on [18 F]GE-180 binding in healthy brain and pseudo-reference regions of neurooncological and neurodegenerative disorders","volume":"11","author":"Vettermann","year":"2021","journal-title":"Life."},{"key":"B222","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13550-022-00878-y","article-title":"Dimethyl fumarate decreases short-term but not long-term inflammation in a focal EAE model of neuroinflammation","volume":"12","author":"Vainio","year":"2022","journal-title":"EJNMMI Res."},{"key":"B223","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1002\/cmdc.201900023","article-title":"Radiosynthesis of (R,S)-[18 F]GE387: a potential PET radiotracer for imaging translocator protein 18 kDa (TSPO) with low binding sensitivity to the human gene polymorphism rs6971","volume":"14","author":"Qiao","year":"2019","journal-title":"ChemMedChem."},{"key":"B224","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.ejmech.2019.05.008","article-title":"(R)-[18 F]NEBIFQUINIDE: a promising new PET tracer for TSPO imaging","volume":"176","author":"Berroter\u00e1n-Infante","year":"2019","journal-title":"Eur J Med Chem."},{"key":"B225","doi-asserted-by":"publisher","first-page":"e984","DOI":"10.1212\/NXI.0000000000000984","article-title":"Microglia activation in basal ganglia is a late event in Huntington Disease pathophysiology","volume":"8","author":"Rocha","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B226","doi-asserted-by":"publisher","first-page":"320","DOI":"10.2967\/jnumed.116.178996","article-title":"11C-ER176, a Radioligand for 18-kDa translocator protein, has adequate sensitivity to robustly image all three affinity genotypes in human brain","volume":"58","author":"Ikawa","year":"2017","journal-title":"J Nucl Med."},{"key":"B227","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13550-017-0334-8","article-title":"Comparison of four 11 C-labeled PET ligands to quantify translocator protein 18 kDa (TSPO) in human brain: (R)-PK11195, PBR28, DPA-713, and ER176-based on recent publications that measured specific-to-non-displaceable ratios","volume":"7","author":"Fujita","year":"2017","journal-title":"EJNMMI Res."},{"key":"B228","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1007\/s00259-019-04349-w","article-title":"Head-to-head comparison of 11 C-PBR28 and 11 C-ER176 for quantification of the translocator protein in the human brain","volume":"46","author":"Zanotti-Fregonara","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B229","doi-asserted-by":"publisher","first-page":"16731","DOI":"10.1021\/acs.jmedchem.1c01562","article-title":"Synthesis and screening in mice of fluorine-containing PET radioligands for TSPO: discovery of a promising 18 F-labeled ligand","volume":"64","author":"Sim\u00e9on","year":"2021","journal-title":"J Med Chem."},{"key":"B230","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.263168","article-title":"In vivo evaluation of six analogs of 11 C-ER176 as candidate 18 F-labeled radioligands for translocator protein 18 kDa (TSPO)","author":"Lee","year":"2022","journal-title":"J Nucl Med."},{"key":"B231","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00259-021-05495-w","article-title":"Preclinical evaluation of (S)-[18 F]GE387, a novel 18-kDa translocator protein (TSPO) PET radioligand with low binding sensitivity to human polymorphism rs6971","volume":"49","author":"Ramakrishnan","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B232","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s00259-021-05482-1","article-title":"Modelling [18 F]LW223 PET data using simplified imaging protocols for quantification of TSPO expression in the rat heart and brain","volume":"49","author":"MacAskill","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B233","doi-asserted-by":"publisher","first-page":"536","DOI":"10.2967\/jnumed.120.243600","article-title":"Quantification of macrophage-driven inflammation during myocardial infarction with 18 F-LW223, a novel TSPO radiotracer with binding independent of the rs6971 human polymorphism","volume":"62","author":"MacAskill","year":"2021","journal-title":"J Nucl Med."},{"key":"B234","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1007\/s00259-021-05617-4","article-title":"Radiosynthesis and characterization of [18 F]BS224: a next-generation TSPO PET ligand insensitive to the rs6971 polymorphism","volume":"49","author":"Lee","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B235","doi-asserted-by":"publisher","first-page":"7785","DOI":"10.1016\/j.biomaterials.2012.07.022","article-title":"PET Imaging of tumor associated macrophages using mannose coated 64Cu liposomes","volume":"33","author":"Locke","year":"2012","journal-title":"Biomaterials."},{"key":"B236","doi-asserted-by":"publisher","first-page":"413","DOI":"10.7150\/thno.15712","article-title":"Noninvasive imaging of myocardial inflammation in myocarditis using 68 Ga-tagged mannosylated human serum albumin positron emission tomography","volume":"7","author":"Lee","year":"2017","journal-title":"Theranostics."},{"key":"B237","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1245\/s10434-014-3986-x","article-title":"Gallium-68 neomannosylated human serum albumin-based PET\/CT lymphoscintigraphy for sentinel lymph node mapping in non-small cell lung cancer","volume":"22","author":"Eo","year":"2015","journal-title":"Ann Surg Oncol."},{"key":"B238","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.nucmedbio.2010.09.010","article-title":"Development of 68Ga-labeled mannosylated human serum albumin (MSA) as a lymph node imaging agent for positron emission tomography","volume":"38","author":"Choi","year":"2011","journal-title":"Nucl Med Biol."},{"key":"B239","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.2967\/jnumed.116.172650","article-title":"Novel PET Imaging of atherosclerosis with 68Ga-labeled NOTA-neomannosylated human serum albumin","volume":"57","author":"Kim","year":"2016","journal-title":"J Nucl Med."},{"key":"B240","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/BF00253423","article-title":"Experimental study for cancer diagnosis with positron-labeled fluorinated glucose analogs: [18F]-2-fluoro-2-deoxy-D-mannose: a new tracer for cancer detection","volume":"7","author":"Fukuda","year":"1982","journal-title":"Eur J Nucl Med."},{"key":"B241","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/jcbfm.1991.92","article-title":"Estimation of local cerebral glucose utilization by positron emission tomography: comparison of [18F]2-fluoro-2-deoxy-D-glucose and [18F]2-fluoro-2-deoxy-D-mannose in patients with focal brain lesions","volume":"11","author":"Wienhard","year":"1991","journal-title":"J Cereb Blood Flow Metab."},{"key":"B242","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.2967\/jnumed.118.223727","article-title":"Molecular Imaging of the Glomerulus via Mesangial Cell Uptake of Radiolabeled Tilmanocept","volume":"60","author":"Qin","year":"2019","journal-title":"J Nucl Med."},{"key":"B243","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.2967\/jnumed.115.156828","article-title":"PET imaging of macrophage mannose receptor-expressing macrophages in tumor stroma using 18F-radiolabeled camelid single-domain antibody fragments","volume":"56","author":"Blykers","year":"2015","journal-title":"J Nucl Med."},{"key":"B244","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.jcmg.2018.07.027","article-title":"Nanobody-facilitated multiparametric PET\/MRI phenotyping of atherosclerosis","volume":"12","author":"Senders","year":"2019","journal-title":"JACC Cardiovasc Imaging."},{"key":"B245","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1007\/s11307-018-01302-5","article-title":"Clinical translation of [68 Ga]Ga-NOTA-anti-MMR-sdAb for PET\/CT imaging of protumorigenic macrophages","volume":"21","author":"Xavier","year":"2019","journal-title":"Mol imaging Biol."},{"key":"B246","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13550-019-0474-0","article-title":"Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using 68 Ga-NOTA-anti-MMR nanobody: non-invasive imaging of atherosclerotic plaques","volume":"9","author":"Varasteh","year":"2019","journal-title":"EJNMMI Res."},{"key":"B247","first-page":"1153","article-title":"Synthesis and preclinical evaluation of a folic acid derivative labeled with 18F for PET imaging of folate receptor-positive tumors","volume":"47","author":"Bettio","year":"2006","journal-title":"J Nucl Med."},{"key":"B248","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1021\/bc800356r","article-title":"Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative","volume":"19","author":"Ross","year":"2008","journal-title":"Bioconjug Chem."},{"key":"B249","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1007\/s00259-010-1597-8","article-title":"Development of new folate-based PET radiotracers: preclinical evaluation of 68Ga-DOTA-folate conjugates","volume":"38","author":"Fani","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B250","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.2967\/jnumed.110.079756","article-title":"new 18F-labeled folic acid derivative with improved properties for the PET imaging of folate receptor-positive tumors","volume":"51","author":"Ross","year":"2010","journal-title":"J Nucl Med."},{"key":"B251","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.nucmedbio.2011.03.004","article-title":"Rapid synthesis and in vitro and in vivo evaluation of folic acid derivatives labeled with fluorine-18 for PET imaging of folate receptor-positive tumors","volume":"38","author":"Jammaz","year":"2011","journal-title":"Nucl Med Biol."},{"key":"B252","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1021\/bc200660z","article-title":"[18F]fluoro-deoxy-glucose folate: a novel PET radiotracer with improved in vivo properties for folate receptor targeting","volume":"23","author":"Fischer","year":"2012","journal-title":"Bioconjug Chem."},{"key":"B253","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.nucmedbio.2012.02.005","article-title":"Novel synthesis and preclinical evaluation of folic acid derivatives labeled with (18)F-[FDG] for PET imaging of folate receptor-positive tumors","volume":"39","author":"Al Jammaz","year":"2012","journal-title":"Nucl Med Biol."},{"key":"B254","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s11307-013-0651-x","article-title":"Improved PET imaging of tumors in mice using a novel (18) F-folate conjugate with an albumin-binding entity","volume":"15","author":"Fischer","year":"2013","journal-title":"Mol imaging Biol."},{"key":"B255","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1021\/mp200418f","article-title":"In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates","volume":"9","author":"Fani","year":"2012","journal-title":"Mol Pharm."},{"key":"B256","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/978-3-642-27994-2_13","article-title":"A novel (68)Ga-labeled pteroic acid-based pet tracer for tumor imaging via the folate receptor","volume":"194","author":"K\u00fchle","year":"2013","journal-title":"Recent Results Cancer Res."},{"key":"B257","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1021\/bc300483a","article-title":"Radiosynthesis and preclinical evaluation of 3'-Aza-2'-[(18)F]fluorofolic acid: a novel PET radiotracer for folate receptor targeting","volume":"24","author":"Betzel","year":"2013","journal-title":"Bioconjug Chem."},{"key":"B258","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13550-020-00624-2","article-title":"Radiation dosimetry of 18 F-AzaFol: a first in-human use of a folate receptor PET tracer","volume":"10","author":"Gnesin","year":"2020","journal-title":"EJNMMI Res."},{"key":"B259","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.3389\/fimmu.2019.02724","article-title":"18 F-AzaFol for detection of folate receptor-\u03b2 positive macrophages in experimental interstitial lung disease-a proof-of-concept study","volume":"10","author":"Schniering","year":"2019","journal-title":"Front Immunol."},{"key":"B260","doi-asserted-by":"publisher","first-page":"R37","DOI":"10.1186\/ar4191","article-title":"Evaluation of the novel folate receptor ligand [18F]fluoro-PEG-folate for macrophage targeting in a rat model of arthritis","volume":"15","author":"Gent","year":"2013","journal-title":"Arthritis Res Ther."},{"key":"B261","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.trsl.2018.04.001","article-title":"Prophylactic and therapeutic activity of alkaline phosphatase in arthritic rats: single-agent effects of alkaline phosphatase and synergistic effects in combination with methotrexate","volume":"199","author":"Chandrupatla","year":"2018","journal-title":"Transl Res."},{"key":"B262","doi-asserted-by":"publisher","first-page":"8092781","DOI":"10.1155\/2018\/8092781","article-title":"Imaging and methotrexate response monitoring of systemic inflammation in arthritic rats employing the macrophage PET Tracer [18 F]Fluoro-PEG-Folate","volume":"2018","author":"Chandrupatla","year":"2018","journal-title":"Contrast Media Mol Imaging."},{"key":"B263","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/s41598-020-57841-x","article-title":"First in man study of [18 F]fluoro-PEG-folate PET: a novel macrophage imaging technique to visualize rheumatoid arthritis","volume":"10","author":"Verweij","year":"2020","journal-title":"Sci Rep."},{"key":"B264","doi-asserted-by":"publisher","first-page":"3103","DOI":"10.1021\/mp4001684","article-title":"Comparative analysis of folate derived PET imaging agents with [(18)F]-2-fluoro-2-deoxy-d-glucose using a rodent inflammatory paw model","volume":"10","author":"Kularatne","year":"2013","journal-title":"Mol Pharm."},{"key":"B265","first-page":"6547","article-title":"Development and pre-clinical evaluation of new 68Ga-NOTA-folate conjugates for PET imaging of folate receptor-positive tumors","volume":"34","author":"Aljammaz","year":"2014","journal-title":"Anticancer Res."},{"key":"B266","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1007\/s11307-017-1049-y","article-title":"Development of a new folate-derived Ga-68-based PET imaging agent","volume":"19","author":"Brand","year":"2017","journal-title":"Mol imaging Biol."},{"key":"B267","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1021\/acs.bioconjchem.5b00644","article-title":"Comparative studies of three pairs of \u03b1- and \u03b3-conjugated folic acid derivatives labeled with fluorine-18","volume":"27","author":"Boss","year":"2016","journal-title":"Bioconjug Chem."},{"key":"B268","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1021\/acs.molpharmaceut.5b00989","article-title":"Synthesis and preclinical evaluation of folate-NOTA-Al(18)F for PET imaging of folate-receptor-positive tumors","volume":"13","author":"Chen","year":"2016","journal-title":"Mol Pharm."},{"key":"B269","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1021\/acs.molpharmaceut.6b00143","article-title":"(64)Cu- and (68)Ga-based PET imaging of folate receptor-positive tumors: development and evaluation of an albumin-binding NODAGA-folate","volume":"13","author":"Farkas","year":"2016","journal-title":"Mol Pharm."},{"key":"B270","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/jlcr.3410","article-title":"Synthesis and biological evaluation of (68) Ga-labeled Pteroyl-Lys conjugates for folate receptor-targeted tumor imaging","volume":"59","author":"Zhang","year":"2016","journal-title":"J Labelled Comp Radiopharm."},{"key":"B271","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.apradiso.2016.07.024","article-title":"Synthesis and evaluation of a (68)Ga labeled folic acid derivative for targeting folate receptors","volume":"116","author":"Jain","year":"2016","journal-title":"Appl Radiat Isot."},{"key":"B272","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.2147\/IJN.S134379","article-title":"A generic 89 Zr labeling method to quantify the in vivo pharmacokinetics of liposomal nanoparticles with positron emission tomography","volume":"12","author":"Li","year":"2017","journal-title":"Int J Nanomed."},{"key":"B273","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/jlcr.3563","article-title":"Synthesis and evaluation of 68 Ga-HBED-CC-EDBE-folate for positron-emission tomography imaging of overexpressed folate receptors on CT26 tumor cells","volume":"61","author":"Choi","year":"2018","journal-title":"J Labelled Comp Radiopharm."},{"key":"B274","doi-asserted-by":"publisher","first-page":"4353","DOI":"10.1021\/acs.molpharmaceut.7b00415","article-title":"Folate-PEG-NOTA-Al 18 F: a new folate based radiotracer for PET imaging of folate receptor-positive tumors","volume":"14","author":"Chen","year":"2017","journal-title":"Mol Pharm."},{"key":"B275","doi-asserted-by":"publisher","first-page":"6113","DOI":"10.1039\/C7NR09269E","article-title":"64 Cu-Labeled multifunctional dendrimers for targeted tumor PET imaging","volume":"10","author":"Ma","year":"2018","journal-title":"Nanoscale."},{"key":"B276","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/ph11010030","article-title":"Comparison study of two differently clicked 18 F-folates-lipophilicity plays a key role","volume":"11","author":"Kettenbach","year":"2018","journal-title":"Pharmaceuticals."},{"key":"B277","doi-asserted-by":"publisher","first-page":"9720","DOI":"10.1038\/s41598-018-27618-4","article-title":"Aluminum fluoride-18 labeled folate enables in vivo detection of atherosclerotic plaque inflammation by positron emission tomography","volume":"8","author":"Silvola","year":"2018","journal-title":"Sci Rep."},{"key":"B278","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.2967\/jnumed.119.241356","article-title":"Folate receptor \u03b2-targeted PET imaging of macrophages in autoimmune myocarditis","volume":"61","author":"Jahandideh","year":"2020","journal-title":"J Nucl Med."},{"key":"B279","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.21873\/anticanres.13359","article-title":"Synthesis of 68 Ga-labeled biopolymer-based nanoparticle imaging agents for positron-emission tomography","volume":"39","author":"K\u00f6rhegyi","year":"2019","journal-title":"Anticancer Res."},{"key":"B280","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3390\/ph12040166","article-title":"New 55 co-labeled albumin-binding folate derivatives as potential PET agents for folate receptor imaging","volume":"12","author":"Radford","year":"2019","journal-title":"Pharmaceuticals."},{"key":"B281","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.3390\/molecules25112712","article-title":"Pharmacokinetic properties of 68 Ga-labelled folic acid conjugates: improvement using HEHE Tag","volume":"25","author":"Larenkov","year":"2020","journal-title":"Molecules."},{"key":"B282","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.3390\/molecules25122922","article-title":"Tumor targeting effect of triphenylphosphonium cations and folic acid coated with Zr-89-labeled silica nanoparticles","volume":"25","author":"Kim","year":"2020","journal-title":"Molecules."},{"key":"B283","doi-asserted-by":"publisher","first-page":"13593","DOI":"10.1038\/s41598-020-70394-3","article-title":"Radiosynthesis and preclinical evaluation of [68 Ga]Ga-NOTA-folate for PET imaging of folate receptor \u03b2-positive macrophages","volume":"10","author":"Moisio","year":"2020","journal-title":"Sci Rep."},{"key":"B284","doi-asserted-by":"publisher","first-page":"3226","DOI":"10.3390\/ma14123226","article-title":"Synthesis of Zr-89-labeled folic acid-conjugated silica (SiO 2) microwire as a tumor diagnostics carrier for positron emission tomography","volume":"14","author":"Kim","year":"2021","journal-title":"Materials."},{"key":"B285","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s11307-020-01543-3","article-title":"In vivo imaging of local inflammation: monitoring LPS-induced CD80\/CD86 upregulation by PET","volume":"23","author":"Taddio","year":"2021","journal-title":"Mol imaging Biol."},{"key":"B286","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1021\/jm960481q","article-title":"Synthesis and evaluation of two positron-labeled nitric oxide synthase inhibitors, S-[11C]methylisothiourea and S-(2-[18F]fluoroethyl)isothiourea, as potential positron emission tomography tracers","volume":"39","author":"Zhang","year":"1996","journal-title":"J Med Chem."},{"key":"B287","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2174\/1874471010801020049","article-title":"Radiosynthesis of 8-Fluoro-3-(4-[18F]Fluorophenyl)-3,4-Dihydro-1-Isoquinolinamine ([18F]FFDI), a potential PET radiotracer for the inducible nitric oxide synthase","volume":"1","author":"Tian","year":"2008","journal-title":"Curr Radiopharm."},{"key":"B288","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1021\/jm801556h","article-title":"Design and synthesis of 2-amino-4-methylpyridine analogues as inhibitors for inducible nitric oxide synthase and in vivo evaluation of [18F]6-(2-fluoropropyl)-4-methyl-pyridin-2-amine as a potential PET tracer for inducible nitric oxide synthase","volume":"52","author":"Zhou","year":"2009","journal-title":"J Med Chem."},{"key":"B289","doi-asserted-by":"publisher","first-page":"994","DOI":"10.2967\/jnumed.111.088518","article-title":"Feasibility and dosimetry studies for 18F-NOS as a potential PET radiopharmaceutical for inducible nitric oxide synthase in humans","volume":"53","author":"Herrero","year":"2012","journal-title":"J Nucl Med."},{"key":"B290","doi-asserted-by":"publisher","first-page":"76","DOI":"10.2967\/jnumed.114.146381","article-title":"Imaging pulmonary inducible nitric oxide synthase expression with PET","volume":"56","author":"Huang","year":"2015","journal-title":"J Nucl Med."},{"key":"B291","doi-asserted-by":"publisher","first-page":"9996125","DOI":"10.1155\/2021\/9996125","article-title":"Automated Synthesis and Initial Evaluation of (4'-Amino-5',8'-difluoro-1'H-spiro[piperidine-4,2'-quinazolin]-1-yl)(4-[18 F]fluorophenyl)methanone for PET\/MR Imaging of Inducible Nitric Oxide Synthase","volume":"2021","author":"Yeh","year":"2021","journal-title":"Mol Imaging."},{"key":"B292","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1148\/radiol.2016161409","article-title":"PET-based Imaging of Chemokine Receptor 2 in experimental and disease-related lung inflammation","volume":"283","author":"Liu","year":"2017","journal-title":"Radiology."},{"key":"B293","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1111\/ajt.13907","article-title":"Noninvasive imaging of CCR2 + cells in ischemia-reperfusion injury after lung transplantation","volume":"16","author":"Liu","year":"2016","journal-title":"Am J Transplant."},{"key":"B294","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1161\/ATVBAHA.117.310517","article-title":"Visualization of monocytic cells in regressing atherosclerotic plaques by intravital 2-photon and positron emission tomography-based imaging-brief report","volume":"38","author":"Li","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"B295","doi-asserted-by":"publisher","first-page":"e010495","DOI":"10.1161\/CIRCIMAGING.120.010495","article-title":"Targeted imaging of abdominal aortic aneurysm: biology over structure","volume":"13","author":"Dobrucki","year":"2020","journal-title":"Circ Cardiovasc Imaging."},{"key":"B296","doi-asserted-by":"publisher","first-page":"e009889","DOI":"10.1161\/CIRCIMAGING.119.009889","article-title":"CCR2 positron emission tomography for the assessment of abdominal aortic aneurysm inflammation and rupture prediction","volume":"13","author":"English","year":"2020","journal-title":"Circ Cardiovasc Imaging."},{"key":"B297","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1161\/CIRCRESAHA.118.314030","article-title":"Molecular imaging visualizes recruitment of inflammatory monocytes and macrophages to the injured heart","volume":"124","author":"Heo","year":"2019","journal-title":"Circ Res."},{"key":"B298","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1164\/rccm.202004-1132OC","article-title":"Chemokine receptor 2-targeted molecular imaging in pulmonary fibrosis. A clinical trial","volume":"203","author":"Brody","year":"2021","journal-title":"Am J Respir Crit Care Med."},{"key":"B299","doi-asserted-by":"publisher","first-page":"111","DOI":"10.2967\/jnumed.120.244673","article-title":"Targeted PET imaging of chemokine receptor 2-positive monocytes and macrophages in the injured heart","volume":"62","author":"Heo","year":"2021","journal-title":"J Nucl Med."},{"key":"B300","doi-asserted-by":"publisher","first-page":"102416","DOI":"10.1016\/j.nano.2021.102416","article-title":"Assessment of ultrasmall nanocluster for early and accurate detection of atherosclerosis using positron emission tomography\/computed tomography","volume":"36","author":"Sultan","year":"2021","journal-title":"Nanomedicine."},{"key":"B301","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1021\/acsnano.0c08185","article-title":"CC Chemokine receptor 2-targeting copper nanoparticles for positron emission tomography-guided delivery of gemcitabine for pancreatic ductal adenocarcinoma","volume":"15","author":"Zhang","year":"2021","journal-title":"ACS Nano."},{"key":"B302","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/cmdc.202000728","article-title":"Development of the first potential nonpeptidic positron emission tomography tracer for the imaging of CCR2 receptors","volume":"16","author":"Wagner","year":"2021","journal-title":"ChemMedChem."},{"key":"B303","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1016\/j.bmcl.2017.04.052","article-title":"Synthesis and preliminary biological evaluation of [11 C]methyl (2-amino-5-(benzylthio)thiazolo[4,5-d]pyrimidin-7-yl)-d-leucinate for the fractalkine receptor (CX 3 CR1)","volume":"27","author":"Gao","year":"2017","journal-title":"Bioorg Med Chem Lett."},{"key":"B304","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1093\/jnci\/94.19.1484","article-title":"Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implications for trial design of antiangiogenic antibodies","volume":"94","author":"Jayson","year":"2002","journal-title":"J Natl Cancer Inst."},{"key":"B305","first-page":"5912","article-title":"The development of [(124)I]iodinated-VG76e: a novel tracer for imaging vascular endothelial growth factor in vivo using positron emission tomography","volume":"62","author":"Collingridge","year":"2002","journal-title":"Cancer Res."},{"key":"B306","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.2967\/jnumed.107.041301","article-title":"In vivo VEGF imaging with radiolabeled bevacizumab in a human ovarian tumor xenograft","volume":"48","author":"Nagengast","year":"2007","journal-title":"J Nucl Med."},{"key":"B307","doi-asserted-by":"publisher","first-page":"761","DOI":"10.2967\/jnumed.109.071043","article-title":"89Zr-bevacizumab PET of early antiangiogenic tumor response to treatment with HSP90 inhibitor NVP-AUY922","volume":"51","author":"Nagengast","year":"2010","journal-title":"J Nucl Med."},{"key":"B308","doi-asserted-by":"publisher","first-page":"905","DOI":"10.2967\/jnumed.116.183475","article-title":"89 Zr-Bevacizumab PET: potential early indicator of everolimus efficacy in patients with metastatic renal cell carcinoma","volume":"58","author":"Van Es","year":"2017","journal-title":"J Nucl Med."},{"key":"B309","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2310\/7290.2012.00034","article-title":"Feasibility of vascular endothelial growth factor imaging in human atherosclerotic plaque using (89)Zr-bevacizumab positron emission tomography","volume":"12","author":"Golestani","year":"2013","journal-title":"Mol Imaging."},{"key":"B310","doi-asserted-by":"publisher","first-page":"6306","DOI":"10.1158\/1078-0432.CCR-12-0406","article-title":"Measurement of tumor VEGF-A levels with 89Zr-bevacizumab PET as an early biomarker for the antiangiogenic effect of everolimus treatment in an ovarian cancer xenograft model","volume":"18","author":"Van Der Bilt","year":"2012","journal-title":"Clin Cancer Res."},{"key":"B311","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.2967\/jnumed.112.117218","article-title":"89Zr-bevacizumab PET imaging in primary breast cancer","volume":"54","author":"Gaykema","year":"2013","journal-title":"J Nucl Med."},{"key":"B312","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.2967\/jnumed.113.129056","article-title":"Everolimus reduces (89)Zr-bevacizumab tumor uptake in patients with neuroendocrine","volume":"55","author":"Van Asselt","year":"2014","journal-title":"Tumors J Nucl Med."},{"key":"B313","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1016\/j.ejca.2014.06.008","article-title":"Visualising dual downregulation of insulin-like growth factor receptor-1 and vascular endothelial growth factor-A by heat shock protein 90 inhibition effect in triple negative breast cancer","volume":"50","author":"Van Scheltinga","year":"2014","journal-title":"Eur J Cancer."},{"key":"B314","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2967\/jnumed.114.144840","article-title":"89Zr-bevacizumab PET visualizes heterogeneous tracer accumulation in tumor lesions of renal cell carcinoma patients and differential effects of antiangiogenic treatment","volume":"56","author":"Oosting","year":"2015","journal-title":"J Nucl Med."},{"key":"B315","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.2967\/jnumed.115.167643","article-title":"89Zr-Bevacizumab PET visualizes disease manifestations in patients with von Hippel-Lindau Disease","volume":"57","author":"Oosting","year":"2016","journal-title":"J Nucl Med."},{"key":"B316","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1158\/1535-7163.MCT-15-0558","article-title":"Bevacizumab targeting diffuse intrinsic pontine glioma: results of 89Zr-bevacizumab PET imaging in brain tumor models","volume":"15","author":"Jansen","year":"2016","journal-title":"Mol Cancer Ther."},{"key":"B317","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2967\/jnumed.116.180216","article-title":"Molecular drug imaging: 89 Zr-Bevacizumab PET in children with diffuse intrinsic pontine glioma","volume":"58","author":"Jansen","year":"2017","journal-title":"J Nucl Med."},{"key":"B318","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1349-7006.2010.01763.x","article-title":"Positron emission tomography imaging and biodistribution of vascular endothelial growth factor with 64Cu-labeled bevacizumab in colorectal cancer xenografts","volume":"102","author":"Paudyal","year":"2011","journal-title":"Cancer Sci."},{"key":"B319","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1158\/0008-5472.CAN-10-1088","article-title":"VEGF-PET imaging is a noninvasive biomarker showing differential changes in the tumor during sunitinib treatment","volume":"71","author":"Nagengast","year":"2011","journal-title":"Cancer Res."},{"key":"B320","first-page":"1","article-title":"Positron emission tomography and near-infrared fluorescence imaging of vascular endothelial growth factor with dual-labeled bevacizumab","volume":"2","author":"Zhang","year":"2012","journal-title":"Am J Nucl Med Mol Imaging."},{"key":"B321","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3109\/02713683.2012.727521","article-title":"Pharmacokinetic properties of intravitreal I-124-aflibercept in a rabbit model using PET\/CT","volume":"37","author":"Christoforidis","year":"2012","journal-title":"Curr Eye Res."},{"key":"B322","doi-asserted-by":"publisher","first-page":"58949","DOI":"10.1371\/journal.pone.0058949","article-title":"Detection of rapalog-mediated therapeutic response in renal cancer xenografts using 64Cu-bevacizumab immunoPET","volume":"8","author":"Chang","year":"2013","journal-title":"PLoS ONE."},{"key":"B323","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.2967\/jnumed.113.130898","article-title":"Development of a radiolabeled irreversible peptide ligand for PET imaging of vascular endothelial growth factor","volume":"55","author":"Marquez","year":"2014","journal-title":"J Nucl Med."},{"key":"B324","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/jcbfm.2011.147","article-title":"An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28","volume":"32","author":"Owen","year":"2012","journal-title":"J Cereb Blood Flow Metab."},{"key":"B325","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2967\/jnumed.110.079459","article-title":"Mixed-affinity binding in humans with 18-kDa translocator protein ligands","volume":"52","author":"Owen","year":"2011","journal-title":"J Nucl Med."},{"key":"B326","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1042\/BST20150058","article-title":"The methodology of TSPO imaging with positron emission tomography","volume":"43","author":"Turkheimer","year":"2015","journal-title":"Biochem Soc Trans."},{"key":"B327","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13550-021-00786-7","article-title":"In vitro and pilot in vivo imaging of 18 kDa translocator protein (TSPO) in inflammatory vascular disease","volume":"11","author":"Schollhammer","year":"2021","journal-title":"EJNMMI Res."},{"key":"B328","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/77","article-title":"2-deoxy-2-[18F]fluoro-D-mannose positron emission tomography imaging in atherosclerosis","volume":"20","author":"Tahara","year":"2014","journal-title":"Nat Med."},{"key":"B329","first-page":"1003","article-title":"Tumor-Selective Radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate","volume":"37","author":"Mathias","year":"1996","journal-title":"J Nucl Med."},{"key":"B330","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/S0969-8051(03)00080-5","article-title":"Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals","volume":"30","author":"Mathias","year":"2003","journal-title":"Nucl Med Biol."},{"key":"B331","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.2967\/jnumed.112.107540","article-title":"unique matched quadruplet of terbium radioisotopes for PET and SPECT and for \u03b1- and \u03b2- radionuclide therapy: an in vivo proof-of-concept study with a new receptor-targeted folate derivative","volume":"53","author":"M\u00fcller","year":"2012","journal-title":"J Nucl Med."},{"key":"B332","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.nucmedbio.2014.03.013","article-title":"Development and preclinical evaluation of new (124)I-folate conjugates for PET imaging of folate receptor-positive tumors","volume":"41","author":"AlJammaz","year":"2014","journal-title":"Nucl Med Biol."},{"key":"B333","doi-asserted-by":"publisher","first-page":"8939","DOI":"10.1039\/C5TB01866H","article-title":"Theranostic CuS nanoparticles targeting folate receptors for PET image-guided photothermal therapy","volume":"3","author":"Zhou","year":"2015","journal-title":"J Mater Chem B."},{"key":"B334","doi-asserted-by":"publisher","first-page":"4361","DOI":"10.1093\/rheumatology\/keaa806","article-title":"Ultrasonographic Halo Score in giant cell arteritis: association with intimal hyperplasia and ischaemic sight loss","volume":"60","author":"Van Der Geest","year":"2021","journal-title":"Rheumatology."},{"key":"B335","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/art.40044","article-title":"A randomized, double-blind trial of abatacept (CTLA-4Ig) for the treatment of giant cell arteritis","volume":"69","author":"Langford","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"B336","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.3899\/jrheum.210455","article-title":"Abatacept as adjunctive therapy in refractory polymyalgia rheumatica","volume":"48","author":"Toussirot","year":"2021","journal-title":"J Rheumatol."},{"key":"B337","doi-asserted-by":"publisher","first-page":"e000353","DOI":"10.1136\/rmdopen-2016-000353","article-title":"Is vascular endothelial growth factor a useful biomarker in giant cell arteritis?","volume":"3","author":"Goodfellow","year":"2017","journal-title":"RMD Open."},{"key":"B338","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1002\/art.38625","article-title":"Disturbed B cell homeostasis in newly diagnosed giant cell arteritis and polymyalgia rheumatica","volume":"66","author":"Van Der Geest","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"B339","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.2967\/jnumed.108.060426","article-title":"Recombinant anti-CD20 antibody fragments for small-animal PET imaging of B-cell lymphomas","volume":"50","author":"Olafsen","year":"2009","journal-title":"J Nucl Med."},{"key":"B340","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/protein\/gzp081","article-title":"ImmunoPET imaging of B-cell lymphoma using 124I-anti-CD20 scFv dimers (diabodies)","volume":"23","author":"Olafsen","year":"2010","journal-title":"Protein Eng Des Sel."},{"key":"B341","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3233\/HAB-2011-0239","article-title":"CD20 antigen imaging with 124I-rituximab PET\/CT in patients with rheumatoid arthritis","volume":"20","author":"Tran","year":"2011","journal-title":"Hum Antibodies."},{"key":"B342","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3233\/HAB-2011-0237","article-title":"The pharmacokinetics of 124I-rituximab in patients with rheumatoid arthritis","volume":"20","author":"Tran","year":"2011","journal-title":"Hum Antibodies."},{"key":"B343","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s11307-013-0624-0","article-title":"Evaluation of 89Zr-rituximab tracer by Cerenkov luminescence imaging and correlation with PET in a humanized transgenic mouse model to image NHL","volume":"15","author":"Natarajan","year":"2013","journal-title":"Mol Imaging Biol."},{"key":"B344","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1007\/s00259-015-3025-6","article-title":"Tumour targeting and radiation dose of radioimmunotherapy with (90)Y-rituximab in CD20+ B-cell lymphoma as predicted by (89)Zr-rituximab immuno-PET: impact of preloading with unlabelled rituximab","volume":"42","author":"Muylle","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B345","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/ajh.24328","article-title":"(89) Zr-rituximab PET\/CT to detect neurolymphomatosis","volume":"91","author":"de Jong","year":"2016","journal-title":"Am J Hematol."},{"key":"B346","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s11307-014-0810-8","article-title":"Radiation dosimetry study of [(89)Zr]rituximab tracer for clinical translation of B cell NHL imaging using positron emission tomography","volume":"17","author":"Natarajan","year":"2015","journal-title":"Mol Imaging Biol."},{"key":"B347","doi-asserted-by":"publisher","first-page":"e0169828","DOI":"10.1371\/journal.pone.0169828","article-title":"Performance of 89Zr-labeled-rituximab-PET as an imaging biomarker to assess CD20 targeting: a pilot study in patients with relapsed\/refractory diffuse large B cell lymphoma","volume":"12","author":"Jauw","year":"2017","journal-title":"PLoS ONE."},{"key":"B348","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13075-016-1166-z","article-title":"B-cell imaging with zirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24weeks after initiation of rituximab treatment in rheumatoid arthritis patients","volume":"18","author":"Bruijnen","year":"2016","journal-title":"Arthritis Res Ther."},{"key":"B349","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2310\/7290.2014.00055","article-title":"Validation of 64Cu-DOTA-rituximab injection preparation under good manufacturing practices: a PET tracer for imaging of B-cell non-Hodgkin lymphoma","volume":"14","author":"Natarajan","year":"2015","journal-title":"Mol Imaging."},{"key":"B350","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1007\/s11307-011-0537-8","article-title":"Positron emission tomography of 64Cu-DOTA-Rituximab in a transgenic mouse model expressing human CD20 for clinical translation to image NHL","volume":"14","author":"Natarajan","year":"2012","journal-title":"Mol imaging Biol."},{"key":"B351","doi-asserted-by":"publisher","first-page":"6820","DOI":"10.1158\/1078-0432.CCR-13-0626","article-title":"A novel engineered anti-CD20 tracer enables early time PET imaging in a humanized transgenic mouse model of B-cell non-Hodgkins lymphoma","volume":"19","author":"Natarajan","year":"2013","journal-title":"Clin Cancer Res."},{"key":"B352","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00259-018-4214-x","article-title":"18 F-labeled anti-human CD20 cys-diabody for same-day immunoPET in a model of aggressive B cell lymphoma in human CD20 transgenic mice","volume":"46","author":"Zettlitz","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B353","doi-asserted-by":"publisher","first-page":"7242","DOI":"10.1158\/1078-0432.CCR-17-0855","article-title":"ImmunoPET of malignant and normal B cells with 89Zr- and 124I-labeled obinutuzumab antibody fragments reveals differential CD20 internalization in vivo","volume":"23","author":"Zettlitz","year":"2017","journal-title":"Clin Cancer Res"},{"key":"B354","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1136\/ard.2005.036533","article-title":"Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis","volume":"64","author":"Bhatia","year":"2005","journal-title":"Ann Rheum Dis."},{"key":"B355","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-022-05706-y","article-title":"Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond","author":"Li","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B356","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.3390\/molecules20022081","article-title":"Evaluation of the radiolabeled boronic acid-based FAP inhibitor MIP-1232 for atherosclerotic plaque imaging","volume":"20","author":"Meletta","year":"2015","journal-title":"Molecules."},{"key":"B357","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.2967\/jnumed.118.210443","article-title":"Development of quinoline-based theranostic ligands for the targeting of fibroblast activation protein","volume":"59","author":"Lindner","year":"2018","journal-title":"J Nucl Med."},{"key":"B358","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s41181-020-00102-z","article-title":"Targeting fibroblast activation protein (FAP): next generation PET radiotracers using squaramide coupled bifunctional DOTA and DATA 5m chelators","volume":"5","author":"Moon","year":"2020","journal-title":"EJNMMI Radiopharm Chem."},{"key":"B359","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1007\/s00259-020-05132-y","article-title":"Biodistribution, pharmacokinetics, dosimetry of [68 Ga]Ga-DOTASAFAPi, and the head-to-head comparison with [18 F]F-FDG PET\/CT in patients with various cancers","volume":"48","author":"Ballal","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B360","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s00259-020-04946-0","article-title":"68 Ga-NOTA-FAPI-04 PET\/CT in a patient with primary gastric diffuse large B cell lymphoma: comparisons with [18 F] FDG PET\/CT","volume":"48","author":"Wang","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B361","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.2967\/jnumed.118.224469","article-title":"Development of fibroblast activation protein-targeted radiotracers with improved tumor retention","volume":"60","author":"Loktev","year":"2019","journal-title":"J Nucl Med."},{"key":"B362","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262533","article-title":"Albumin binder-conjugated fibroblast activation protein inhibitor radiopharmaceuticals for cancer therapy","author":"Xu","year":"2021","journal-title":"J Nucl Med."},{"key":"B363","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-021-05591-x","article-title":"Fatty acid-conjugated radiopharmaceuticals for fibroblast activation protein-targeted radiotherapy","author":"Zhang","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B364","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1021\/acssensors.1c01316","article-title":"Rational design, pharmacomodulation, and synthesis of [68 Ga]Ga-Alb-FAPtp-01, a selective tumor-associated fibroblast activation protein tracer for PET imaging of glioma","volume":"6","author":"Lin","year":"2021","journal-title":"ACS Sensors."},{"key":"B365","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.2967\/jnumed.121.263016","article-title":"Synthesis, preclinical evaluation, and a pilot clinical PET imaging study of 68 Ga-labeled FAPI dimer","volume":"49","author":"Zhao","year":"2021","journal-title":"J Nucl Med."},{"key":"B366","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.2967\/jnumed.120.242958","article-title":"Targeting fibroblast activation protein: radiosynthesis and preclinical evaluation of an 18 F-labeled FAP inhibitor","volume":"61","author":"Toms","year":"2020","journal-title":"J Nucl Med."},{"key":"B367","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1007\/s00259-021-05470-5","article-title":"Clinical translational evaluation of Al 18 F-NOTA-FAPI for fibroblast activation protein-targeted tumour imaging","volume":"48","author":"Wang","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B368","doi-asserted-by":"publisher","first-page":"296","DOI":"10.2967\/jnumed.120.256271","article-title":"FAPI PET\/CT: will it end the hegemony of 18F-FDG in oncology?","volume":"62","author":"Hicks","year":"2021","journal-title":"J Nucl Med."},{"key":"B369","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab664","article-title":"Targeting of fibroblast activation protein in rheumatoid arthritis patients: imaging and ex vivo photodynamic therapy","author":"Dorst","year":"2021","journal-title":"Rheumatology."},{"key":"B370","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.jcmg.2009.04.016","article-title":"18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis","volume":"2","author":"Nahrendorf","year":"2009","journal-title":"JACC Cardiovasc Imaging."},{"key":"B371","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1093\/ehjci\/jev346","article-title":"Targeting of vascular cell adhesion molecule-1 by 18F-labelled nanobodies for PET\/CT imaging of inflamed atherosclerotic plaques","volume":"17","author":"Bala","year":"2016","journal-title":"Eur Hear journal Cardiovasc Imaging."},{"key":"B372","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1021\/acs.molpharmaceut.7b00961","article-title":"Imaging of VCAM-1 expression and monitoring therapy response in tumor with a 68 Ga-labeled single chain variable fragment","volume":"15","author":"Zhang","year":"2018","journal-title":"Mol Pharm."},{"key":"B373","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.3390\/pharmaceutics13071025","article-title":"Two novel PET radiopharmaceuticals for endothelial vascular cell adhesion molecule-1 (VCAM-1) Targeting","volume":"13","author":"Pastorino","year":"2021","journal-title":"Pharmaceutics."},{"key":"B374","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s12350-014-0061-8","article-title":"Feasibility of [18F]-RGD for ex vivo imaging of atherosclerosis in detection of \u03b1v\u03b23 integrin expression","volume":"22","author":"Golestani","year":"2015","journal-title":"J Nucl Cardiol."},{"key":"B375","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1007\/s00259-020-04975-9","article-title":"Non-oncological applications of RGD-based single-photon emission tomography and positron emission tomography agents","volume":"48","author":"Ebenhan","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B376","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.3390\/molecules26061792","article-title":"PET diagnostic molecules utilizing multimeric cyclic RGD peptide analogs for imaging integrin \u03b1v\u03b23 receptors","volume":"26","author":"Liolios","year":"2021","journal-title":"Molecules."},{"key":"B377","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1161\/01.RES.77.6.1129","article-title":"\u03b1v\u03b23 integrin expression in normal and atherosclerotic artery","volume":"77","author":"Hoshiga","year":"1995","journal-title":"Circ Res."},{"key":"B378","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jcmg.2013.12.003","article-title":"PET\/CT imaging of integrin \u03b1v\u03b23 expression in human carotid atherosclerosis","volume":"7","author":"Beer","year":"2014","journal-title":"JACC Cardiovasc Imaging."},{"key":"B379","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13550-021-00842-2","article-title":"There is a world beyond \u03b1v\u03b23-integrin: Multimeric ligands for imaging of the integrin subtypes \u03b1v\u03b26, \u03b1v\u03b28, \u03b1v\u03b23, and \u03b15\u03b21 by positron emission tomography","volume":"11","author":"Steiger","year":"2021","journal-title":"EJNMMI Res."},{"key":"B380","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/852748","article-title":"Human epidermal growth factor receptor 2 (HER2) in cancers: overexpression and therapeutic implications","volume":"2014","author":"Iqbal","year":"2014","journal-title":"Mol Biol Int."},{"key":"B381","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.2967\/jnumed.112.118612","article-title":"64Cu-DOTA-trastuzumab PET imaging in patients with HER2-positive breast cancer","volume":"54","author":"Tamura","year":"2013","journal-title":"J Nucl Med."},{"key":"B382","doi-asserted-by":"publisher","first-page":"892","DOI":"10.2967\/jnumed.109.073239","article-title":"Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68Ga-labeled affibody molecules","volume":"51","author":"Baum","year":"2010","journal-title":"J Nucl Med."},{"key":"B383","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1038\/clpt.2010.12","article-title":"Biodistribution of 89Zr-trastuzumab and PET imaging of HER2-positive lesions in patients with metastatic breast cancer","volume":"87","author":"Dijkers","year":"2010","journal-title":"Clin Pharmacol Ther."},{"key":"B384","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1093\/annonc\/mdv577","article-title":"Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial","volume":"27","author":"Gebhart","year":"2016","journal-title":"Ann Oncol."},{"key":"B385","doi-asserted-by":"publisher","first-page":"366","DOI":"10.2967\/jnumed.120.244897","article-title":"Immuno-PET detects changes in multi-RTK tumor cell expression levels in response to targeted kinase inhibition","volume":"62","author":"Pereira","year":"2021","journal-title":"J Nucl Med."},{"key":"B386","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1038\/s41386-020-00866-7","article-title":"A potential biomarker for treatment stratification in psychosis: evaluation of an [18F] FDOPA PET imaging approach","volume":"46","author":"Veronese","year":"2020","journal-title":"Neuropsychopharmacol."},{"key":"B387","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/art.40520","article-title":"Review: what is the current evidence for disease subsets in giant cell arteritis?","volume":"70","author":"van der Geest","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"B388","first-page":"1647","article-title":"99mTc-interleukin-2 scintigraphy as a potential tool for evaluating tumor-infiltrating lymphocytes in melanoma lesions: a validation study","volume":"45","author":"Signore","year":"2004","journal-title":"J Nucl Med."},{"key":"B389","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1093\/rheumatology\/kez034","article-title":"Markers of angiogenesis and macrophage products for predicting disease course and monitoring vascular inflammation in giant cell arteritis","volume":"58","author":"van Sleen","year":"2019","journal-title":"Rheumatology."},{"key":"B390","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1136\/annrheumdis-2021-221865","article-title":"Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial","volume":"81","author":"Cid","year":"2022","journal-title":"Ann Rheum Dis."},{"key":"B391","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11307-014-0768-6","article-title":"Biodistribution and PET imaging of a novel [68Ga]-anti-CD163-antibody conjugate in rats with collagen-induced arthritis and in controls","volume":"17","author":"Eichendorff","year":"2015","journal-title":"Mol Imaging Biol."},{"key":"B392","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1002\/cmdc.201800624","article-title":"Antibody fragment and affibody immunoPET imaging agents: radiolabelling strategies and applications","volume":"13","author":"Fu","year":"2018","journal-title":"ChemMedChem."},{"key":"B393","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/antib8010012","article-title":"Targeted nanobody-based molecular tracers for nuclear imaging and image-guided surgery","volume":"8","author":"Debie","year":"2019","journal-title":"Antibodies."},{"key":"B394","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/978-4-431-55894-1_6","article-title":"How Far Are We from Dose On Demand of Short-Lived Radiopharmaceuticals?","author":"Pascali","year":"2016","journal-title":"Perspect Nucl Med Mol Diagnosis Integr Ther."},{"key":"B395","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1053\/j.semnuclmed.2021.10.003","article-title":"Advancement in production of radiotracers","volume":"52","author":"Hansen","year":"2021","journal-title":"Semin Nucl Med."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.902155\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T05:45:12Z","timestamp":1654494312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.902155\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,6]]},"references-count":395,"alternative-id":["10.3389\/fmed.2022.902155"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.902155","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,6]]},"article-number":"902155"}}